Применение электропорации как альтернатива лучевой терапии

Subject Terms: электропорация, химиотерапия, лучевая терапия, электрическое поле, химические реагенты

File Description: application/pdf

Access URL: http://earchive.tpu.ru/handle/11683/73369

Study of the suppression of a tumor growth expressing a carcinoembryonic antigen with a new high-tech drug carplasmin (CAR-T therapy) in Balb/c nude mice ; Исследование подавления роста опухоли, экспрессирующей раково-эмбриональный антиген, новым высокотехнологичным препаратом карплазмин (CAR-T-терапия) у мышей линии Balb/c nude

Authors: V. K. Bozhenko, A. M. Shishkin, A. N. Shkoporov, Y. Yu. Kiseleva, T. M. Kulinich, O. B. Bolshakova, E. A. Kudinova, V. A. Solodkiy, В. К. Боженко, А. М. Шишкин, А. Н. Шкопоров, Я. Ю. Киселева, Т. М. Кулинич, О. Б. Большакова, Е. А. Кудинова, В. А. Солодкий

Contributors: The study was carried out with the support of the Ministry of Education and Science of Russia (project #14.N08.11.0018)., Исследование выполнено при поддержке Минобрнауки России (проект #14.N08.11.0018).

Source: Advances in Molecular Oncology; Том 10, № 1 (2023); 79-86 ; Успехи молекулярной онкологии; Том 10, № 1 (2023); 79-86 ; 2413-3787 ; 2313-805X ; 10.17650/2313-805X-2023-10-1

Subject Terms: раково-эмбриональный антиген, chimeric antigen receptors, CAR-T therapy, electroporation, carcinoembryonic antigen, химерный антигенный рецептор, CAR-T-терапия, электропорация

File Description: application/pdf

Relation: https://umo.abvpress.ru/jour/article/view/514/293; Arabi F., Torabi-Rahvar M., Shariati A. et al. Antigenic targets of CAR T cell therapy. A retrospective view on clinical trials. Exp Cell Res 2018;369(1):1–10. DOI:10.1016/j.yexcr.2018.05.009; Brentjens R.J., Davila M.L., Riviere I. et al. CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapyrefractory acute lymphoblastic leukemia. Sci Transl Med 2013;5(177):177ra38. DOI:10.1126/scitranslmed.3005930; Kuehn B.M. The promise and challenges of CAR-T gene therapy. JAMA. 2017;318(22):2167–9. DOI:10.1001/jama.2017.15605; Bjerner J., Lebedin Y., Bellanger L. et al. Protein epitopes in carcinoembryonic antigen. Report of the ISOBM TD8 workshop. Tumour Biol 2002;23(4):249–62. DOI:10.1159/000067255; Шишкин А.М. Разработка метода адоптивной иммунотерапии раково-эмбриональный антиген позитивных опухолей человека: автореф. дис. … канд. мед. наук. М., 2015. 22 с.; Bojenko V.K., Shramova E.I., Shkoporov A.N. et al. Monomolecular chimeric T-cell receptor to a carcinoembryonic antigen. WO2013154458A2, 2013.; Bozhenko V.K., Shramova E.I., Shishkin A.M. et al. Characteristics of new monomolecular chimeric T-cell receptors to carcinoembryonic antigen. Bull Exp Biol Med 2013;156(1): 165–71. DOI:10.1007/s10517-013-2302-2; Skorka K., Ostapinska K., Malesa A. et al. The application of CART cells in haematological malignancies. Arch Immunol Ther Exp (Warsz) 2020;68(6):34. DOI:10.1007/s00005-020-00599-x; Hammarstrom S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 1999;9(2):67–81. DOI:10.1006/scbi.1998.0119; Nap M., Mollgard K., Burtin P. et al. Immunohistochemistry of carcino-embryonic antigen in the embryo, fetus and adult. Tumour Biol 1988;9(2–3):145–53. DOI:10.1159/000217555; Boucher D., Cournoyer D., Stanners C.P. et al. Studies on the control of gene expression of the carcinoembryonic antigen family in human tissue. Cancer Res 1989;49(4):847–52.; Zhang C., Wang Z., Yang Z. et al. Phase I escalating-dose trial of CAR-T therapy targeting CEA(+) metastatic colorectal cancers. Mol Ther 2017;25(5):1248–58. DOI:10.1016/j.ymthe.2017.03.010; Yoon S.H., Lee J.M., Cho H.I. et al. Adoptive immunotherapy using human peripheral blood lymphocytes transferred with RNA encoding Her-2/neu-specific chimeric immune receptor in ovarian cancer xenograft model. Cancer Gene Ther 2009;16(6):489–97. DOI:10.1038/cgt.2008.98; Barrett D.M., Zhao Y., Liu X. et al. Treatment of advanced leukemia in mice with mRNA engineered T cells. Hum Gene Ther 2011;22(12):1575–86. DOI:10.1089/hum.2011.070; Mitchell D.A., Nair S.K. RNA-transfected dendritic cells in cancer immunotherapy. J Clin Invest 2000;106(9):1065–9. DOI:10.1172/JCI11405; Emtage P.C., Lo A.S., Gomes E.M. et al. Second-generation anticarcinoembryonic antigen designer T cells resist activation-induced cell death, proliferate on tumor contact, secrete cytokines, and exhibit superior antitumor activity in vivo: a preclinical evaluation. Clin Cancer Res 2008;14(24):8112–22. DOI:10.1158/1078-0432.CCR-07-4910; Wang X., Riviere I. Clinical manufacturing of CAR T cells: foundation of a promising therapy. Mol Ther Oncolytics 2016;3:16015. DOI:10.1038/mto.2016.15; https://umo.abvpress.ru/jour/article/view/514

Availability: https://umo.abvpress.ru/jour/article/view/514
https://doi.org/10.17650/2313-805X-2023-10-1-79-86

Percutaneous irreversible electroporation in locally advanced pancreatic cancer – a review and a case report ; Чрескожная необратимая электропорация при местно-распространенном раке поджелудочной железы – обзор литературы и клинический случай

Authors: A. N. Polyakov, Yu. I. Patyutko, I. V. Pogrebnyakov, B. I. Dolgushin, V. N. Sholohov, O. S. Vlasenko, I. S. Bazin, D. M. Kantieva, K. A. Romanova, V. A. Kozhushkov, I. A. Kozhushkov, D. V. Podluzhnyi, А. Н. Поляков, Ю. И. Патютко, И. В. Погребняков, Б. И. Долгушин, В. Н. Шолохов, О. С. Власeнко, И. С. Базин, Д. М. Кантиева, К. А. Романова, В. А. Кожушков, И. А. Кожушков, Д. В. Подлужный

Contributors: The consumables for electroporation were provided by REEPL., Расходные материалы для электропорации предоставлены фирмой REEPL («РИПЛ»).

Source: Surgery and Oncology; Том 13, № 1 (2023); 45-53 ; Хирургия и онкология; Том 13, № 1 (2023); 45-53 ; 2949-5857

Subject Terms: необратимая электропорация, methods of local tumor destruction, combined therapy, flat-detector computed tomography, irreversible electroporation, методы локальной деструкции опухоли, комбинированная терапия, плоскодетекторная компьютерная томография

File Description: application/pdf

Relation: https://www.onco-surgery.info/jour/article/view/596/414; Heestand G.M., Murphy J.D., Lowy A.M. Approach to patients with pancreatic cancer without detectable metastases. J Clin Oncol 2015;1;33(16):1770–8. PMID: 25918279. DOI:10.1200/JCO.2014.59.7930; Suker M., Beumer B.R., Sadot E. et al. Folfirinox for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis. Lancet Oncol 2016;17:801–10. PMID: 27160474. DOI:10.1016/S1470-2045(16)00172-8; Narayanan G., Daye D., Wilson N.M. et al. Ablation in Pancreatic Cancer: Past, Present and Future. Cancers (Basel) 2021;13(11):2511. PMID: 34063784. DOI:10.3390/cancers13112511; Edd J.F., Horowitz L., Davalos R.V. et al. In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng 2006;53(7):1409–15. PMID: 16830945. DOI:10.1109/TBME.2006.873745; Narayanan G., Hosein P.J., Arora G. et al. Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma. J Vasc Interv Radiol 2012;23(12):1613–21. PMID: 23177107. DOI:10.1016/j.jvir.2012.09.012; Saad A.M., Turk T., Al-Husseini M.J., Abdel-Rahman O. Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study. BMC Cancer 2018;18(1):688. PMID: 29940910. DOI:10.1186/s12885-018-4610-4; Balaban E.P., Mangu P.B., Khorana A.A. et al. Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 2016;34(22):2654–68. PMID: 27247216. DOI:10.1200/JCO.2016.67.5561; Spiliopoulos S., Zurlo M.T., Casella A. et al. Current status of non-surgical treatment of locally advanced pancreatic cancer. World J Gastrointest Oncol 2021;13(12):2064–75. PMID: 35070042. DOI:10.4251/wjgo.v13.i12.2064; Hammel P., Huguet F., van Laethem J.L. et al. Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial. JAMA 2016;315(17): 1844–53. PMID: 27139057. DOI:10.1001/jama.2016.4324; Herman J.M., Chang D.T., Goodman K.A. et al. Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma. Cancer 2015;121(7):1128–37. PMID: 25538019. DOI:10.1002/cncr.29161; Reyngold M., O’Reilly E.M., Varghese A.M. et al. Association of Ablative Radiation Therapy With Survival Among Patients With Inoperable Pancreatic Cancer. JAMA Oncol 2021;7(5):735–8. PMID: 33704353. DOI:10.1001/jamaoncol.2021.0057; Zeng X.L., Wang H.H., Meng M.B. et al. Stereotactic body radiation therapy for patients with recurrent pancreatic adenocarcinoma at the abdominal lymph nodes or postoperative stump including pancreatic stump and other stump. Onco Targets Ther 2016;9:3985–92. PMID: 27418841. DOI:10.2147/OTT.S102784; Al-Sakere B., Andre F., Bernat C. et al. Tumor ablation with irreversible electroporation. PloSone 2007;2(11):e1135. PMID: 17989772. DOI:10.1371/journal.pone.0001135; Edelblute C.M., Hornef J., Burcus N.I. et al. Controllable Moderate Heating Enhances the Therapeutic Efficacy of Irreversible Electroporation for Pancreatic Cancer. Sci Rep 2017;7(1): 11767. PMID: 28924200. DOI:10.1038/s41598-017-12227-4; Москвичева Л.И., Петров Л.О., Сидоров Д.В. Возможности современных методов абляции при нерезектабельном местнораспространенном раке поджелудочной железы. Исследования и практика в медицине 2018;5(2):86–99. DOI:10.17709/2409-2231-2018-5-2-10; Wendler J.J., Fischbach K., Ricke J. et al. Irreversible Electroporation (IRE): Standardization of Terminology and Reporting Criteria for Analysis and Comparison. Pol J Radiol 2016;81:54–64. PMID: 26966472. DOI:10.12659/PJR.896034; Martin R.C. 2nd , Kwon D., Chalikonda S. et al. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy. Ann Surg 2015;262(3):486–94. PMID: 26258317. DOI:10.1097/SLA.0000000000001441; Vogel J.A., Rombouts S.J., de Rooij T. et al. Induction Chemotherapy Followed by Resection or Irreversible Electroporation in Locally Advanced Pancreatic Cancer (IMPALA): A Prospective Cohort Study. Ann Surg Oncol 2017;24(9):2734–43. PMID: 28560601. DOI:10.1245/s10434-017-5900-9; Астахов Д.А., Панченков Д.Н., Иванов Ю.В и др. Необратимая электропорация при местно-распространенном раке поджелудочной железы. Анналы хирургической гепатологии 2018;23(2):59–68. DOI:10.16931/1995-5464.2018259-68; Ruarus A.H., Vroomen L.G.P.H., Geboers B. et al. Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study. Radiology 2020;294(1):212–20. PMID: 31687922. DOI:10.1148/radiol.2019191109; Yang P.C., Huang K.W., Pua U. et al. Prognostic factor analysis of irreversible electroporation for locally advanced pancreatic cancer – A multi-institutional clinical study in Asia. Eur J Surg Oncol 2020;46(5):811–7. PMID: 31839436. DOI:10.1016/j.ejso.2019.12.006; Mansson C., Brahmstaedt R., Nilsson A. et al. Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy. Eur J Surg Oncol 2016;42(9):1401–6. PMID: 26906114. DOI:10.1016/j.ejso.2016.01.024; Lafranceschina S., Brunetti O., Delvecchio A. et al. Systematic Review of Irreversible Electroporation Role in Management of Locally Advanced Pancreatic Cancer. Cancers (Basel) 2019;11(11):1718. PMID: 31684186. DOI:10.3390/cancers11111718; Moris D., Machairas N., Tsilimigras D.I. et al. Systematic Review of Surgical and Percutaneous Irreversible Electroporation in the Treatment of Locally Advanced Pancreatic Cancer. Ann Surg Oncol 2019;26(6):1657–68. PMID: 30843163. DOI:10.1245/s10434-019-07261-7

Availability: https://www.onco-surgery.info/jour/article/view/596
https://doi.org/10.17650/2686-9594-2023-13-1-45-53

Repeated irreversible electroporation in a locally advanced pancreatic cancer ; Случай повторного применения необратимой электропорации при местнораспространенном раке поджелудочной железы

Authors: A. N. Polyakov, D. V. Podluzhnyi, N. E. Kudashkin, I. S. Bazin, B. M. Medvedeva, A. Yu. Syskova, D. M. Kantieva, Yu. I. Patyutko, А. Н. Поляков, Д. В. Подлужный, Н. Е. Кудашкин, И. С. Базин, Б. М. Медведева, А. Ю. Сыскова, Д. М. Кантиева, Ю. И. Патютко

Source: Research and Practical Medicine Journal; Том 9, № 4 (2022); 114-122 ; Research'n Practical Medicine Journal; Том 9, № 4 (2022); 114-122 ; 2410-1893 ; 10.17709/2410-1893-2022-9-4

Subject Terms: комбинированное лечение рака поджелудочной железы, ductal adenocarcinoma, local relapse of pancreatic cancer, irreversible electroporation, combined treatment for pancreatic cancer, протоковая аденокарцинома, локальный рецидив рака поджелудочной железы, необратимая электропорация

File Description: application/pdf

Relation: https://www.rpmj.ru/rpmj/article/view/838/517; https://www.rpmj.ru/rpmj/article/downloadSuppFile/838/692; https://www.rpmj.ru/rpmj/article/downloadSuppFile/838/693; https://www.rpmj.ru/rpmj/article/downloadSuppFile/838/694; https://www.rpmj.ru/rpmj/article/downloadSuppFile/838/695; https://www.rpmj.ru/rpmj/article/downloadSuppFile/838/696; https://www.rpmj.ru/rpmj/article/downloadSuppFile/838/697; Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492; Balaban EP, Mangu PB, Khorana AA, Shah MA, Mukherjee S, Crane CH, Javle MM, Eads JR, Allen P, Ko AH, Engebretson A, Herman JM, Strickler JH, Benson AB 3rd, Urba S, Yee NS. Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2016 Aug 1;34(22):2654–2668. https://doi.org/10.1200/JCO.2016.67.5561; Gong J, Tuli R, Shinde A, Hendifar AE. Meta-analyses of treatment standards for pancreatic cancer. Mol. Clin. Oncol. 2016;4:315– 325. https://doi.org/10.3892/mco.2015.716; Vogel JA, van Veldhuisen E, Agnass P, Crezee J, Dijk F, Verheij J, et al. Time-dependent impact of irreversible electroporation on pancreas, liver, blood vessels and nerves: a systematic review of experimental studies. PLoS ONE. 2016;11(11):e0166987. https://doi.org/10.1371/journal.pone.0166987; Martin RC 2nd, Kwon D, Chalikonda S, Sellers M, Kotz E, Scoggins C, et al. Treatment of 200 Locally Advanced (Stage III) Pancreatic Adenocarcinoma Patients With Irreversible Electroporation Safety and Efficacy. Ann Surg 2015;262:486–494. https://doi.org/10.1097/SLA.0000000000001441; Астахов Д. А., Панченков Д. Н., Иванов Ю. В., Шабловский О. Р., Кедрова А. Г., Соловьев Н. А. и др. Необратимая электропорация при местнораспространенном раке поджелудочной железы. Анналы хирургической гепатологии. 2018;23(2):59–68. https://doi.org/10.16931/1995-5464.2018259-68; Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, et al. Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine. N Engl J Med 2013;369:1691–1703. https://doi.org/10.1056/NEJMoa1304369; Conroy T, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, et al. FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer N Engl J Med 2011;364:1817–1825. https://doi.org/10.1056/NEJMoa1011923; Chiorean EG, Cheung WY, Giordano G, Kim G, Al-Batran SE. Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in advanced pancreatic cancer: a systematic review. Ther Adv Med Oncol. 2019 May 19;11:1758835919850367. https://doi.org/10.1177/1758835919850367; Hammel P, Huguet F, van Laethem JL, Goldstein D, Glimelius B, Artru P, et al. Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial. JAMA. 2016;315(17):1844–1853. https://doi.org/10.1001/jama.2016.4324; Ионкин Д. А., Карельская Н. А., Степанова Ю. А., Земсков В. М., Козлова М. Н., Жаворонкова О. А. и др. Криодеструкция при местнораспространенном раке поджелудочной железы. Анналы хирургической гепатологии. 2018;23(2):37–49. https://doi.org/10.16931/1995-5464.2018237-49; Edd JF, Horowitz L, Davalos RV, Mir LM, Rubinsky B. In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Transactions on Bio-medical Engineering 2006;53:1409–1415. https://doi.org/10.1109/TBME.2006.873745; Narayanan G, Hosein PJ, Arora G, Barbery KJ, Froud T, Livingstone AS, et al. Percutaneous Irreversible Electroporation for Downstaging and Control of Unresectable Pancreatic Adenocarcinoma. J Vasc Interv Radiol 2012;23:1613–1621. https://doi.org/10.1016/j.jvir.2012.09.012; https://www.rpmj.ru/rpmj/article/view/838

Availability: https://www.rpmj.ru/rpmj/article/view/838
https://doi.org/10.17709/2410-1893-2022-9-4-11

Импульсные электрические поля – нетермические методы обработки для сохранения продуктов питания

Subject Terms: электропорация, технологии нетепловой обработки, микроволновая вакуумная технология, продукты питания, сохранение продуктов питания, сушка микроволновым излучением, нетермические методы обработки, сушка пищевых продуктов, технологии обезвоживания сырья

File Description: application/pdf

Access URL: https://rep.bsatu.by/handle/doc/15206

Electrical Injury (a Literature Review) ; Электротравма (обзор литературы)

Authors: E. A. Zhirkova, T. G. Spiridonova, A. V. Sachkov, K. V. Svetlov, Е. А. Жиркова, Т. Г. Спиридонова, А. В. Сачков, К. В. Светлов

Source: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 8, № 4 (2019); 443-450 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 8, № 4 (2019); 443-450 ; 2541-8017 ; 2223-9022 ; 10.23934/2223-9022-2019-8-4

Subject Terms: лечение электротравмы, electric burn, bio-exposure of electric current, electrolysis, electroporation, electro-conformational denaturation of membrane proteins, diagnosis of electrical injury, treatment of electrical injury, электроожог, биовоздействие электрического тока, электролиз, электропорация, электроконформационная денатурация мембранных белков, диагностика электротравмы

File Description: application/pdf

Relation: https://www.jnmp.ru/jour/article/view/752/726; https://www.jnmp.ru/jour/article/view/752/821; Спиридонов О.П. Универсальные физические постоянные. Москва: Просвещение; 1984.; Bernstein T. Theories of the causes of death from electricity in the late nineteenth century. Med Instrum. 1975;9(6):267–273. PMID: 1102874; Shih JG, Shahrokhi S, Jeschke MG. Review of adult electrical burn injury outcomes worldwide: an analysis of low-voltage vs highvoltage electrical injury. J Burn Care Res. 2017;38(1):e293–e298. PMID: 27359191 https://doi.org/10.1097/BCR.0000000000000373; Mangelsdorff G, García-Huidobro MA, Nachari I, Atenas O, Whittle S, Villegas J. High voltage electrical burns as a risk factor for mortality among burn patients. Rev Med Chil. 2011;139(2):177–181. PMID: 21773654 https://doi.org/S0034-98872011000200006; DeBono R. A histological analysis of a high voltage electric current injury to an upper limb. Burns. 1999;25(6):541–547. PMID: 10498366 https://doi.org/10.1016/s0305-4179(99)00029-7; Гаряев Р.В., Харатишвили Т.К., Буров Д.А., Костяк О.С. Ятрогенная интраоперационная электротравма лучевого нерва. Cаркомы костей, мягких тканей и опухоли кожи. 2012;(2):65–68.; Koumbourlis AC. Electrical injuries. Crit Care Med. 2002;30(11 Suppl): S424-S430. PMID: 12528784 https://doi.org/10.1097/00003246-200211001-00007; Macmahon HE. Electric Shock. Am J Pathol. 1929;5(4):333–348.5. PMID: 19969856; Hun JL, Mason AD Jr., Masterson TS, Pruitt BA Jr. The pathophysiology of acute electric injuries. J Trauma. 1976;16(5):335–340. PMID: 1271494 https://doi.org/10.1097/00005373-197605000-00001; Шкрабак В.С., Рузанова Н.И. Особенности электропоражений и методы защиты от воздействия электрической дуги. Аграрный научный журнал. 2015;(3):63–66.; Алексеев В.М., Алексеева М.С., Халяпин А.А. Действие электрического тока на организм. Проблемы современной науки и образования. 2016;33(75):25–26.; Назаров Г.Н., Николенко Л.П. Судебно-медицинское исследование электротравмы. Москва: Фолиум; 1992.; Соколов В.А., Степаненко С.А., Петрачков А.Л., Адмакин А.Л. Эпидемиология поражений электрическим током: электротравма и электроожоги (обзор иностранных публикаций). Медико-биологические и социально-психологические проблемы безопасности в чрезвычайных ситуациях. 2014;(4):26–33.; Соукуп Ф. Электричество не прощает: 99 случаев нарушений правил эксплуатации и техники безопасности с указанием их причин и последствий. Москва: Профиздат; 1960.; Sturmer FC. Electrical Burns: A Case Report. Ann Surg. 1961;154(1):120– 124. PMID: 17859667 https://doi.org/10.1097/00000658-196107000- 00018; Кокорев А.С. Электрослесарь по ремонту электрических машин. 2-е изд., перераб. и доп. Москва: Высшая школа; 1983.; Алисевич В.И., Прозоровский В.И. (ред.). Судебная медицина. Москва: Юридическая литература; 1968.; Lee RC, Zhang D, Hannig J. Biophysical injury mechanisms in electrical shock trauma. Annu Rev Biomed Eng. 2000;2:477–509. PMID: 11701521 https://doi.org/10.1146/annurev.bioeng.2.1.477; Block TA, Aarsvold JN, Matthews KL, Mintzer RA, River LP, CapelliSchellpfeffer M, et al. The 1995 Lindberg Award. Nonthermally mediated muscle injury and necrosis in electrical trauma. J Burn Care Rehabil. 1995;16(6):581–588. PMID: 8582934; Bhatt DL, Gaylor DC, Lee RC. Rhabdomyolysis due to pulsed electric fields. Plast Reconstr Surg. 1990;86(1):1–11. PMID: 2359775 https://doi.org/10.1097/00006534-199007000-00001; Chen W, Lee RC. Altered ion channel conductance and ionic selectivity induced by large imposed membrane potential pulse. Biophys J. 1994;67(2):603–612. PMID: 7948676 https://doi.org/10.1016/S0006-3495(94)80520-X; Любин А.В., Солпов А.В., Шаповалов К.Г. Агрегация тромбоцитов и лимфоцитарно-тромбоцитарная адгезия при электротравме в эксперименте. Дальневосточный медицинский журнал. 2012;(1):112–115.; Хрулев А.Е., Григорьева В.Н., Хрулев С.Е. Механизмы поражения и морфологические изменения нервной системы при электрической травме. Саратовский научно-медицинский журнал. 2010;6(2):374– 377.; Фисталь Э. Я. Электротравма (клиника, неотложная помощь и лечение). Лiкування та дiагностика. 1997;(2):57–64.; Teodoreanu R, Popescu SA, Lascar I. Electrical injuries. Biological values measurements as a prediction factor of local evolution in electrocutions lesions. J Med Life. 2014;7(2):226–236. PMID: 25408731; Hooshmand H, Radfar F, Beckner E. The neurophysiological aspects of electrical injuries. Clin Electroencephalogr. 1989;20(2):111–120. PMID: 2706789; Varghese G, Mani MM, Redford JB. Spinal cord injuries following electrical accidents. Paraplegia. 1986;24(3):159–166. PMID: 3748595 https://doi.org/10.1038/sc.1986.21; Mankani MH, Abramov GS, Boddie A, Lee RC. Detection of peripheral nerve injury in electrical shock patients. Ann N Y Acad Sci. 1994;720:206– 212. PMID: 8010639 https://doi.org/10.1111/j.1749-6632.1994.tb30448.x; Newsome TW, Curreri PW, Eurenius K. Visceral injuries: an unusual complication of an electrical burn. Arch Surg. 1972;105(3):494–497. PMID: 5056946 https://doi.org/10.1001/archsurg.1972.04180090097023; Branday JM, DuQuesnay DR, Yeesing MT, Duncan ND. Visceral complications of electrical burn injury. A report of two cases and review of the literature. West Indian Med J. 1989;38(2):110–113. PMID: 2763531; Kobernick M. Electrical injuries: pathophysiology and emergency management. Ann Emerg Med. 1982;11(11):633–638. PMID: 7137674 https://doi.org/10.1016/s0196-0644(82)80211-4; Bongard O, Fagrell B. Delayed arterial thrombosis following an apparently trivial low-voltage electric injury. Vasa. 1989;18(2):162–166. PMID: 2662675; Purdue GF, Hunt JL. Electrocardiographic monitoring after electrical injury: necessity or luxury. J Trauma. 1986;26(2):166–167. PMID: 3944840 https://doi.org/10.1097/00005373-198602000-00013; Grosgurin O, Marti C, Niquille M. Electrical injuries. Rev Med Suisse. 2011;7(305):1569–1573. PMID: 21922721; Geddes LA, Bourland JD, Ford G. The mechanism underlying sudden death from electric shock. Med Instrum. 1986;20(6):303–315. PMID: 3543629; McBride JW, Labrosse KR, McCoy HG, Ahrenholz DH, Solem LD, Goldenberg IF. Is serum creatine kinase-MB in electrically injured patients predictive of myocardial injury? JAMA. 1986;255(6):764–768. PMID: 3944978; Prellwitz W, Kapp S, Neumeier D, Knedel M, Lang H, Heuwinkel D.Isoenzymes of creatine kinase: distribution in the skeletal muscle and in sera of patients with muscular diseases or damages (author’s transl). Klin Wochenschr. 1978;56(11):559–565. PMID: 661151 https://doi.org/10.1007/bf01477252; d’Amato TA, Kaplan IB, Britt LD. High-voltage electrical injury: a role for mandatory exploration of deep muscle compartments. J Natl Med. Assoc. 1994;86(7):535–537. PMID: 8064905; Brandão C, Vaz M, Brito IM, Ferreira B, Meireles R, Ramos S, et al. Electrical burns: a retrospective analysis over a 10-year period. Ann Burns Fire Disasters. 2017;30(4):268–271. PMID: 29983679; Hsueh YY, Chen CL, Pan SC. Analysis of factors influencing limb amputation in high-voltage electrically injured patients. Burns. 2011;37(4):673–677. PMID: 21334820 https://doi.org/10,1016/ j.burns.2011.01.014; Kopp J, Loos B, Spilker G, Horch RE. Correlation between serum creatinine kinase levels and extent of muscle damage in electrical burns. Burns. 2004;30(7):680–683. PMID: 15475142 https://doi.org/10.1016/j.burns.2004.05.008; Hunt J, Lewis S, Parkey R, Baxter C. The use of Technetium-99m stannous pyrophosphate scintigraphy to identify muscle damage in acute electric burns. J Trauma. 1979;19(6):409–413. PMID: 448780 https://doi.org/10.1097/00005373-197906000-00004; Holliman CJ, Saffle JR, Kravitz M, Warden GD. Early surgical decompression in the management of electrical injuries. Am J Surg. 1982;144(6):733–739. PMID: 7149133 https://doi.org/10.1016/0002-9610(82)90560-8; Marques EG, Júnior GA, Neto BF, Freitas RA, Yaegashi LB, Almeida CE, et al. Visceral injury in electrical shock trauma: proposed guideline for the management of abdominal electrocution and literature review. Int J Burns Trauma. 2014;4(1):1–6. PMID: 24624308; Püschel K, Brinkmann B, Lieske K. Ultrastructural alterations of skeletal muscles after electric shock. Am J Forensic Med Pathol. 1985;6(4):296– 300. PMID: 4072983 https://doi.org/10.1097/00000433-198512000- 00005; Apfelberg DB, Masters FW, Robinson DW. Pathophysiology and treatment of lightning injuries. J Trauma. 1974;14(6):453–460. PMID: 4842641 https://doi.org/10.1097/00005373-197406000-00002; Gentges J, Schieche C. Electrical injuries in the emergency department: an evidence-based review. Emerg Med Pract. 2018;20(11):1–20. PMID: 30358379; Gille J, Schmidt T, Dragu A, Emich D, Hilbert-Carius P, Kremer T, et al. Electrical injury — a dual center analysis of patient characteristics, therapeutic specifics and outcome predictors. Scand J Trauma Resusc Emerg Med. 2018;26(1):43. PMID: 29855384 https://doi.org/10.1186/ s13049-018-0513-2; Kym D, Seo DK, Hur GY, Lee JW. Epidemiology of electrical injury: Differences between low- and high-voltage electrical injuries during a 7-year study period in South Korea. Scand J Surg. 2015;104(2):108–114. PMID: 24809357 https://doi.org/10.1177/1457496914534209; Лакатош К.О., Самодай В.Г. Случай успешного хирургического лечения пострадавшего, перенесшего электротравму с поражением головного мозга. Вестник экспериментальной и клинической хирургии. 2010;3(2):165–167.; Сачков А.В. Микрохирургическая аутотрансплантация при ожоге головы. Трансплантология. 2011;(2–3):85–87.; Маликов М. Х., Курбанов У. А., Давлатов А. А. Пересадка васкуляризированных костных трансплантатов при травматических дефектах и ложных суставах костей верхней конечности. Новости хирургии. 2012;20(5):82–90.; Сачков А.В., Смирнов С.В., Мигунов М.А., Степанова Ю.В., Литинский М.А. Перемещение лучевого лоскута на сосудистой ножке для устранения дефекта кисти после электроожога. Трансплантология. 2016;(3):37–40.; Муллин Р.И., Богов А.А., Новиков Р.Г. Ранняя некрэктомия и васкуляризированная кожная пластика при электротравме пальцев кисти. Анналы пластической, реконструктивной и эстетической хирургии. 2016;(1):88–89.; https://www.jnmp.ru/jour/article/view/752

Availability: https://www.jnmp.ru/jour/article/view/752
https://doi.org/10.23934/2223-9022-2019-8-4-443-450

ИНАКТИВАЦИЯ РЕЦЕПТОРА PDGFRβ В КОРЕ ГОЛОВНОГО МОЗГА ПРИВОДИТ К НАРУШЕНИЯМ МИГРАЦИИ И ДИФФЕРЕНЦИРОВКИ НЕЙРОНОВ

Subject Terms: in utero electroporation, neurogenesis, кора головного мозга, cerebral cortex, нейрогенез, in utero электропорация

Трансформация энтомопатогенных грибов: методический обзор

Authors: С.А. Тимофеев, В.С. Журавлев, В.В. Долгих

Source: Вестник защиты растений, Iss 2 (2019)

Subject Terms: энтомопатогенные грибы, трансформация, защита растений, протопласты, агробактерии, электропорация, Plant culture, SB1-1110

File Description: electronic resource

Relation: http://ia.spcras.ru/index.php/vizr/article/view/4790; https://doaj.org/toc/1727-1320; https://doaj.org/toc/2308-6459

Access URL: https://doaj.org/article/d7f90e336d344ea989ed9f352cbf0b2a

Исследование экстракции веществ под действием импульсного электрического поля ; Study of the substance extraction under the pulse electric field

Authors: Петренко, Е. В., Иванов, Анатолий Александрович

Contributors: Юдин, Артём Сергеевич

Subject Terms: растительное сырье, полезные компоненты, электрическое поле, электропорация, межэлектродные промежутки

Relation: Перспективы развития фундаментальных наук : сборник научных трудов XIV Международной конференции студентов, аспирантов и молодых ученых, г. Томск, 25-28 апреля 2017 г. Т. 1 : Физика. — Томск, 2017.; http://earchive.tpu.ru/handle/11683/41466

Availability: http://earchive.tpu.ru/handle/11683/41466

Контроль эффективности электропорации с помощью измерения проводимости тканей ; Control of electroporation efficiency by measuring the conductivity of the tissues

Authors: Пак, Ф. А.

Contributors: Алейник, Александр Никонорович

Subject Terms: электропорация, электрические импульсы, липиды, мембраны, электрический ток

Relation: Перспективы развития фундаментальных наук : сборник научных трудов XIV Международной конференции студентов, аспирантов и молодых ученых, г. Томск, 25-28 апреля 2017 г. Т. 1 : Физика. — Томск, 2017.; http://earchive.tpu.ru/handle/11683/41463

Availability: http://earchive.tpu.ru/handle/11683/41463

Modern methods of ablation of malignant tumors of the liver ; Современные методы абляции злокачественных новообразований печени

Authors: L. I. Moskvicheva, D. V. Sidorov, M. V. Lozhkin, L. O. Petrov, M. V. Zabelin, Л. И. Москвичева, Д. В. Сидоров, М. В. Ложкин, Л. О. Петров, М. В. Забелин

Source: Research and Practical Medicine Journal; Том 5, № 4 (2018); 58-71 ; Research'n Practical Medicine Journal; Том 5, № 4 (2018); 58-71 ; 2410-1893 ; 10.17709/2409-2231-2018-5-4

Subject Terms: стереотаксическая лучевая терапия, hepatocellular carcinoma, hepatic metastases, radiofrequency ablation, microwave ablation, high-intensity focused ultrasound therapy, laser ablation, cryoablation, percutaneous ethanol injection, irreversible electroporation, stereotactic body radiation therapy, метастатическое поражение печени, радиочастотная абляция, микроволновая абляция, высокоинтенсивная фокусированная ультразвуковая терапия, лазерная абляция, криоабляция, химическая абляция, необратимая электропорация

File Description: application/pdf

Relation: https://www.rpmj.ru/rpmj/article/view/322/272; Злокачественные новообразования в России в 2015 году (заболеваемость и смертность). Под ред. Каприна А. Д., Ста-ринского В. В., Петровой Г. В. М.: МНИОИ им. П. А. Герцена — филиал ФГБУ «НМИРЦ» Минздрава России; 2017, 250 с./Ma-lignant neoplasms in Russia in 2015 (morbidity and mortality). Edited by Kaprin A. D., Starinsky V. V., Petrova G. V. Moscow: P. Hertsen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Centre of the Ministry of Health of the Russian Federation; 2017, р. 250 (In Russian).; Состояние онкологической помощи населению России в 2017 году. Под ред. Каприна А. Д., Старинского В. В., Петровой Г. В. М.: МНИОИ им. П. А. Герцена — филиал ФГБУ «НМИЦ радиологии» Минздрава России; 2018, 236 с./The state of cancer care in Russia in 2017. Edited by Kaprin A. D., Starinsky V. V., Petrova G. V. Moscow: P. Hertsen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Centre of the Ministry of Health of the Russian Federation; 2018, р. 236 (In Russian).; Лунев С. В., Сельчук В. Ю., Чистяков С. С. Современные подходы к хирургическому лечению опухолей печени. Русский медицинский журнал. 2011;2:44-47./Lunev SV, Selchuk VYu, Chistyakov SS. Modern approaches to surgical treatment of liver tumors. Russian Medical Journal. 2011;2:44-47. (In Russian).; Hackl C, Neumann P, Gerken M, Loss M, Klinkhammer-Schal-ke M, Schlitt HJ. Treatment of colorectal liver metastases in Germany: A ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma. BMC Cancer. 2014 Nov 4;14:810. DOI:10.1186/1471-2407-14-810; de Haas RJ, Wicherts DA, Flores E, Ducreux M, Levi F, Paule B, et al. Tumor Marker Evolution: Comparison with Imaging for Assessment of Response to Chemotherapy in Patients with Colorectal Liver Metastases. Ann Surg Oncol. 2010 Apr;17 (4):1010-23. DOI:10.1245/s10434-009-0887-5.; Вишневский В. А., Ефанов М. Г., Икрамов Р. З., Чжао А. В. Опухоли печени: диагностика и хирургическое лечение. Доказательная гастроэнтерология. 2013;2:38-47./Vishnevsky VA, Efanov MG, Ikramov RZ, Zhao AV. Hepatic tumours: diagnostics and surgical treatment. Russian Journal of Evidence-Based Gastroenterology (Dokazatel'naya gastroenterologiya). 2013;2:38-47. (In Russian).; Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. Gastroenterology. 2004 Nov;127 (5 Suppl 1): S35-50.; Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008 Jul 24;359 (4):378-90. DOI:10.1056/NEJMoa0708857; Labib PL, Davidson BR, Sharma RA, Pereira SP. Locoregion-al therapies in cholangiocarcinoma. Hepat Oncol. 2017 Oct;4 (4):99-109. DOI:10.2217/hep-2017-0014; Hansen PD, Cassera MA, Wolf RF. Ablative technologies for hepatocellular, cholangiocarcinoma, and metastatic colorectal cancer of the liver. Surg Oncol Clin N Am. 2015 Jan;24 (1):97-119. DOI:10.1016/j.soc.2014.09.003.; Knavel EM, Brace CL. Tumor ablation: common modalities and general practices. Tech Vasc Interv Radiol. 2013 Dec;16 (4):192-200. DOI:10.1053/j.tvir.2013.08.002.; Napoletano C, Taurino F, Biffoni M, De Majo A, Coscarella G, Bellati F, et al. RFA strongly modulates the immune system and anti-tumor immune responses in metastatic liver patients. Int J Oncol. 2008 Feb;32 (2):481-90.; Reuter NP, Woodall CE, Scoggins CR, McMasters KM, Martin RC. Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent? J Gastrointest Surg. 2009 Mar;13 (3):486-91. DOI:10.1007/s11605-008-0727-0.; Agcaoglu O, Aliyev S, Karabulut K, El-Gazzaz G, Aucejo F, Pel-ley R, et al. Complementary use of resection and radiofrequency ablation for the treatment of colorectal liver metastases: an analysis of 395 patients. World J Surg. 2013 Jun;37 (6):1333-9. DOI:10.1007/s00268-013-1981-1; Razafindratsira Т, Isamber М, Evrard S. Complications of intraoperative radiofrequency ablation of liver metastases. HPB. 2011;13:15-23. https://doi.org/10.1111/j.1477-2574.2010.00243.x; Berber E, Siperstein A. Local recurrence after laparoscopic radiofrequency ablation of liver tumors: an analysis of 1032 tumors. Ann Surg Oncol. 2008 Oct;15 (10):2757-64. DOI:10.1245/s10434-008-0043-7; Nielsen K, van Tilborg AA, Meijerink MR, Macintosh MO, Zon-derhuis BM, de Lange ES, et al. Incidence and treatment of local site recurrences following RFA of colorectal liver metastases. World J Surg. 2013 Jun;37 (6):1340-7. DOI:10.1007/s00268-013-1997-6.; Van Tilborg AA, Meijerink MR, Sietses C, Van Waesberghe JH, Mackintosh MO, Meijer S, et al. Long term results of radiofrequency ablation for unresectable colorectal liver metastases: a potentially curative intervention. Br J Radiol. 2011 Jun;84 (1002):556-65. DOI:10.1259/bjr/78268814.; Kim KH, Yoon YS, Yu CS, Kim TW, Kim HJ, Kim PN, et al. Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases. J Korean Surg Soc. 2011 Jul;81 (1):25-34. DOI:10.4174/jkss.2011.81.1.25; Ruers T, Punt C, Van Coevorden F, Pierie JP, Borel-Rinkes I, Ledermann JA, et al. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). Ann Oncol. 2012 Oct;23 (10):2619-26. DOI:10.1093/annonc/mds053; Ruers T, Van Coevorden F, Punt CJ, Pierie JE, Borel-Rinkes I, Ledermann JA, et al. Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial. J Natl Cancer Inst. 2017 Sep 1;109 (9). DOI:10.1093/jnci/djx015.; Kim YS, Lim HK, Rhim H, Lee MW, Choi D, Lee WJ, et al. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol. 2013 Jan;58 (1):89-97. DOI:10.1016/j.jhep.2012.09.020; Pompili M, Mirante VG, Rondinara G, Fassati LR, Piscaglia F, Agnes S, et al. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transpl. 2005 Sep;11 (9):1117-26. DOI:10.1002/lt.20469; Brillet PY, Paradis V, Brancatelli G, Rangheard AS, Consigny Y, Plessier A, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma before liver transplantation: a prospective study with histopathologic comparison. AJR Am J Roentgenol. 2006 May;186 (5 Suppl): S296-305. DOI:10.2214/AJR.04.1927; Sun Y, Cheng Z, Dong L, Zhang G, Wang Y, Liang P. Comparison of temperature curve and ablation zone between 915-and 2450-MHz cooled-shaft microwave antenna: results in ex vivo porcine livers. Eur J Radiol. 2012 Mar;81 (3):553-7. DOI:10.1016/j.ejrad.2011.02.013.; Shady W, Petre EN, Do KG, Gonen M, Yarmohammadi H, Brown KT, et al. Percutaneous Microwave versus Radiofrequency Ablation of Colorectal Liver Metastases: Ablation with Clear Margins (A0) Provides the Best Local Tumor Control. J Vasc Interv Radiol. 2018 Feb;29 (2):268-275.e1. DOI:10.1016/j.jvir.2017.08.021.; Song P, Sheng L, Sun Y, An Y, Guo Y, Zhang Y. The clinical utility and outcomes of microwave ablation for colorectal cancer liver metastases. Oncotarget. 2017 Feb 9;8 (31):51792-51799. DOI:10.18632/oncotarget.15244.; Zhou F, Yu X, Liang P, Han Z, Cheng Z, Yu J, et al. Does primary tumor location impact the prognosis of colorectal liver metastases patients after microwave ablation? — Lessons from 10 years' experience. Oncotarget. 2017 Jun 28;8 (59):100791-100800. DOI:10.18632/oncotarget.18764.; Livraghi T, Meloni F, Solbiati L, Zanus G, Noto A, Goleffi O, et al. Complications of microwave ablation for liver tumors: results of a multicenter study. Cardiovasc Intervent Radiol. 2012 Aug;35 (4):868—74. DOI:10.1007/s00270-011-0241-8; Shibata T, Niinobu T, Ogata N, Takami M. Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer. 2000 Jul 15;89 (2):276-84.; Alexander ES, Wolf FJ, Machan JT, Charpentier KP, Beland MD, Iannuccilli JD, et al. Microwave ablation of focal hepatic malignancies regardless of size: A 9-year retrospective study of 64 patients. Eur J Radiol. 2015 Jun;84 (6):1083-90. DOI:10.1016/j. ejrad.2015.02.027; Huo YR, Eslick GD. Microwave ablation compared to radiofrequency ablation for hepatic lesions: a meta-analysis. J Vasc Interv Radiol. 2015 Aug;26 (8):1139-1146.e2. DOI:10.1016/j.jvir.2015.04.004.; Eng OS, Tsang AT, Moore D, Chen C, Narayanan S, Gannon CJ, et al. Outcomes of microwave ablation for colorectal cancer liver metastases: a single center experience. J Surg Oncol. 2015 Mar 15;111 (4):410-3. DOI:10.1002/jso.23849.; Sun AX, Cheng ZL, Wu PP, Sheng YH, Qu XJ, Lu W, et al. Clinical outcome of medium-sized hepatocellular carcinoma treated with microwave ablation. World J Gastroenterol. 2015 Mar 14;21 (10):2997-3004. DOI:10.3748/wjg.v21.i10.2997.; Ginsburg M, Zivin SP, Wroblewski K, Doshi T, Vasnani RJ, Van Ha TG. Comparison of Combination Therapies in the Management of Hepatocellular Carcinoma: Transarterial Chemoemboli-zation with Radiofrequency Ablation versus Microwave Ablation. J Vasc Interv Radiol. 2015 Mar;26 (3):330-41. DOI:10.1016/j.jvir.2014.10.047.; van den Bijgaart RJ, Eikelenboom DC, Hoogenboom M, Futter-er JJ, den Brok MH, Adema GJ. Thermal and mechanical high-intensity focused ultrasound: perspectives on tumor ablation, immune effects and combination strategies. Cancer Immunol Immunother. 2017 Feb;66 (2):247-258. DOI:10.1007/s00262-016-1891-9.; Dupre A, Melodelima D, Perol D, Chen Y, Vincenot J, Chapelon JY, Rivoire M. First Clinical Experience of Intra-Operative High Intensity Focused Ultrasound in Patients with Colorectal Liver Metastases: A Phase I-IIa Study. PLoS One. 2015 Feb 26;10 (2): e0118212. DOI:10.1371/journal.pone.0118212.; Mearini L. High intensity focused ultrasound, liver disease and bridging therapy. World J Gastroenterol. 2013 Nov 21;19 (43):7494-9. DOI:10.3748/wjg.v19.i43.7494.; Li JJ, Gu MF, Luo GY, Liu LZ, Zhang R, Xu GL. Complications of high intensity focused ultrasound for patients with hepatocellular carcinoma. Technol Cancer Res Treat. 2009 Jun;8 (3):217-24. DOI:10.1177/153303460900800306; Xu G, Luo G, He L, Li J, Shan H, Zhang R, Li Y, et al. Follow-up of high-intensity focused ultrasound treatment for patients with hepatocellular carcinoma. Ultrasound Med Biol. 2011 Dec;37 (12):1993-9. DOI:10.1016/j.ultrasmedbio.2011.08.011; Ng KK, Poon RT, Chan SC, Chok KS, Cheung TT, Tung H, Chu F, et al. High-intensity focused ultrasound for hepatocellular carcinoma. Ann Surg. 2011 May;253 (5):981-7. DOI:10.1097/SLA.0b013e3182128a8b.; Cheung TT, Fan ST, Chu FS, Jenkins CR, Chok KS, Tsang SH, et al. Survival analysis of high-intensity focused ultrasound ablation in patients with small hepatocellular carcinoma. HPB (Oxford). 2013 Aug;15 (8):567-73. DOI:10.1111/hpb.12025.; Wu F, Wang ZB, Chen WZ, Zou JZ, Bai J, Zhu H, et al. Advanced hepatocellular carcinoma: treatment with high intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology. 2005 May;235 (2):659-67. DOI:10.1148/ra-diol.2352030916; Vogl TJ, Farshid P, Naguib NN, Darvishi A, Bazrafshan B, Mbal-isike E, et al. Thermal ablation of liver metastases from colorectal cancer: radiofrequency, microwave and laser ablation therapies. Radiol Med. 2014 Jul;119 (7):451-61. DOI:10.1007/s11547-014-0415-y; Di Costanzo GG, D'Adamo G, Tortora R, Zanfardino F, Mat-tera S, Francica G, Pacella CM. A novel needle guide system to perform percutaneous laser ablation of liver tumors using the multifiber technique. Acta Radiol. 2013 Oct;54 (8):876-81. DOI:10.1177/0284185113489825.; Tombesi P, Di Vece F, Sartori S. Laser ablation for hepatic metastases from neuroendocrine tumors. AJR Am J Roentgenol. 2015 Jun;204 (6): W732. DOI:10.2214/AJR.14.14242.; Facciorusso A, Serviddio G, Muscatiello N. Local ablative treatments for hepatocellular carcinoma: An updated review. World J Gastrointest Pharmacol Ther. 2016 Nov 6;7 (4):477-489. DOI:10.4292/wjgpt.v7.i4.477; Yu H, Burke CT. Comparison of Percutaneous Ablation Technologies in the Treatment of Malignant Liver Tumors. Semin Intervent Radiol. 2014 Jun;31 (2):129-37. DOI:10.1055/s-0034-1373788.; Eichler K, Zangos S, Gruber-Rouh T, Vogl TJ, Mack MG. Magnetic resonance-guided laser-induced thermotherapy in patients with oligonodular hepatocellular carcinoma: long-term results over a 15-year period. J Clin Gastroenterol. 2012 Oct;46 (9):796-801. DOI:10.1097/MCG.0b013e3182641806; Sartori S, Di Vece F, Ermili F, Tombesi P. Laser ablation of liver tumors: An ancillary technique, or an alternative to radiofrequency and microwave? World J Radiol. 2017 Mar 28;9 (3):91-96. doi:10.4329/wjr.v9.i3.91.; Di Costanzo GG, Tortora R, D'Adamo G, De Luca M, Lampasi F, Addario L, et al. Radiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma in cirrhosis: a randomized trial. J Gastroenterol Hepatol. 2015 Mar;30 (3):559-65. DOI:10.1111/jgh.12791.; Qu J, Gao X, Chen Y, Zhou L, Wu Y, Feng Y, et al. Outcomes of ultrasound-guided percutaneous argon-helium cryoablation of hepatocellular carcinoma. J Hepatobiliary Pancreat Sci. 2012 Nov;19 (6):674-84. DOI:10.1007/s00534-011-0490-6.; Glazer DI, Tatli S, Shyn PB, Vangel MG, Tuncali K, Silverman SG. Percutaneous Image-Guided Cryoablation of Hepatic Tumors: Single-Center Experience With Intermediate to LongTerm Outcomes. AJR Am J Roentgenol. 2017 Dec;209 (6):1381-1389. DOI:10.2214/AJR.16.17582; Kemeny N. The management of resectable and unresectable liver metastases from colorectal cancer. Curr Opin Oncol. 2010 Jul;22 (4):364-73. DOI:10.1097/CCO.0b013e32833a6c8a; Wu B, Xiao YY, Zhang X, Zhang AL, Li HJ, Gao DF. Magnetic resonance imaging-guided percutaneous cryoablation of hepatocellular carcinoma in special regions. Hepatobiliary Pancreat Dis Int. 2010 Aug;9 (4):384-92.; Rong G, Bai W, Dong Z, Wang C, Lu Y, Zeng Z, et al. Long-Term Outcomes of Percutaneous Cryoablation for Patients with Hepatocellular Carcinoma within Milan Criteria. PLoS One. 2015 Apr 7;10 (4): e0123065. DOI:10.1371/journal.pone.0123065; Xu K-C, Niu L-Z, He W-B, Hu Y-Z, Zuo J-S. Percutaneous cryosurgery for the treatment of hepatic colorectal metastases. World J Gastroenterol. 2008 Mar 7;14 (9):1430-6.; Shimizu T, Sakuhara Y, Abo D, Hasegawa Y, Kodama Y, Endo H, et al. Outcome of MR-guided percutaneous cryoabla-tion for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2009;16:816-823. https://doi.org/10.1007/s00534-009-0124-4; Bageacu S, Kaczmarek D, Lacroix M, Dubois J, Forest J, Porche-ron J. Cryosurgery for resectable and unresectable hepatic metastases from colorectal cancer. Eur J Surg Oncol. 2007 Jun;33 (5):590-6. DOI:10.1016/j.ejso.2007.01.003; Xu K-C, Niu L-Z, Zhou Q, Hu Y-Z, Guo D-H, Liu Z-P, et al. Sequential use of transarterial chemoembolization and percutaneous cryosurgery for hepatocellular carcinoma. World J Gastroenterol. 2009 Aug 7;15 (29):3664-9.; McCarley JR, Soulen MC. Percutaneous ablation of hepatic tumors. Semin Intervent Radiol. 2010 Sep;27 (3):255-60. DOI:10.1055/s-0030-1261783.; Mahnken AH, Bruners P, Gunther RW. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation. Dig Dis. 2009;27 (2):148-56. DOI:10.1159/000218347.; Kwon JH. Is percutaneous ethanol injection therapy still effective for hepatocellular carcinoma in the era of radiofrequency ablation? Gut Liver. 2010 Sep;4 Suppl 1: S105-12. DOI:10.5009/gnl.2010.4.S1.S105; Jansen MC, van Hillegersberg R, Chamuleau RA, van Delden OM, Gouma DJ, van Gulik TM. Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review. Eur J Surg Oncol. 2005 May;31 (4):331-47. DOI:10.1016/j.ejso.2004.10.011; Giorgio A, Di Sarno A, De Stefano G, Scognamiglio U, Farel-la N, Mariniello A, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma compared to percutaneous ethanol injection in treatment of cirrhotic patients: an Italian randomized controlled trial. Anticancer Res. 2011 Jun;31 (6):2291-5.; Ansari D, Andersson R. Radiofrequency ablation or percutaneous ethanol injection for the treatment of liver tumors. World J Gastroenterol. 2012 Mar 14;18 (10):1003-8. DOI:10.3748/wjg. v18.i10.1003; Ebara M, Okabe S, Kita K, Sugiura N, Fukuda H, Yoshika-wa M, et al. Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year ob-servation. J Hepatol. 2005 Sep;43 (3):458-64. DOI:10.1016/j.jhep.2005.03.033; Dettmer A, Kirchhoff TD, Gebel M, Zender L, Malek NP, Panning B, et al. Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma. World J Gastroenterol. 2006 Jun 21;12 (23):3707-15.; Livraghi T, Lazzaroni S, Meloni F, Solbiati L. Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br J Surg. 2005 Jul;92 (7):856-8. DOI:10.1002/bjs.4986; Lau WY, Leung TW, Yu SC, Ho SK. Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg. 2003 Feb;237 (2):171-9. DOI:10.1097/01.SLA.0000048443.71734.BF; Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut. 2005 Aug;54 (8):1151-6. DOI:10.1136/gut.2004.045203; Zhang YJ, Liang HH, Chen MS, Guo RP, Li JQ, Zheng Y, et al. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial. Radiology. 2007 Aug;244 (2):599-607. DOI:10.1148/radi-ol.2442060826; Branco F, Bru C, Vilana R, Bianchi L, Alves de Mattos A. Percutaneous ethanol injection before liver transplantation in the hepatocellular carcinoma. Ann Hepatol. 2009 Jul-Sep;8 (3):220-7.; Zimmerman A, Grand D, Charpentier KP. Irreversible electroporation of hepatocellular carcinoma: patient selection and perspectives. J Hepatocell Carcinoma. 2017 Mar 13;4:49-58. DOI:10.2147/JHC.S129063.; Qasrawi R, Silve L, Burdio F, Abdeen Z, Ivorra A. Anatomically Realistic Simulations of Liver Ablation by Irreversible Electroporation: Impact of Blood Vessels on Ablation Volumes and Undertreatment. Technol Cancer Res Treat. 2017 Jan 1:1533034616687477. DOI:10.1177/1533034616687477.; Ruarus AH, Vroomen LGPH, Puijk RS, Scheffer HJ, Zonderhu-is BM, Kazemier G, et al. Irreversible Electroporation in Hepa-topancreaticobiliary Tumours. Can Assoc Radiol J. 2018 Feb;69 (1):38-50. DOI:10.1016/j.carj.2017.10.005.; Dollinger M, Muller-Wille R, Zeman F, Haimerl M, Niessen C, Beyer LP, et al. Irreversible electroporation of malignant hepatic tumors — alterations in venous structures at subacute follow-up and evolution at mid-term follow-up. PLoS One. 2015 Aug 13;10 (8): e0135773. DOI:10.1371/journal.pone.0135773.; Dollinger M, Zeman F, Niessen C, Lang SA, Beyer LP, Muller M, et al. Bile duct injury after irreversible electroporation of hepatic malignancies: evaluation of MR imaging findings and laboratory values. J Vasc Interv Radiol. 2016 Jan;27 (1):96-103. DOI:10.1016/j.jvir.2015.10.002; Niessen C, Beyer LP, Pregler B, Dollinger M, Trabold B, Schlit-t=HJ, et al. Percutaneous ablation of hepatic tumors using irreversible electroporation: a prospective safety and midterm efficacy study in 34 patients. J Vasc Interv Radiol. 2016 Apr;27 (4):480-6. DOI:10.1016/j.jvir.2015.12.025; Bhutiani N, Philips P, Scoggins CR, McMasters KM, Potts MH, Martin RCG. Evaluation of tolerability and efficacy of irreversible electroporation (IRE) in treatment of Child-Pugh B (7/8) hepatocellular carcinoma (HCC). HPB (Oxford). 2016 Jul;18 (7):593-9. DOI:10.1016/j.hpb.2016.03.609; Donadon M, Solbiati L, Dawson L, Barry A, Sapisochin G, Greig PD, et al. Hepatocellular Carcinoma: The Role of Interventional Oncology. Liver Cancer. 2016 Nov;6 (1):34-43. DOI:10.1159/000449346; Lyu T, Wang X, Su Z, Shangguan J, Sun C, Figini M, et al. Irreversible electroporation in primary and metastatic hepatic malignancies. A review. Medicine (Baltimore). 2017 Apr;96 (17): e6386. DOI:10.1097/MD.0000000000006386.; Niessen C, Thumann S, Beyer L, Pregler B, Kramer J, Lang S, et al. Percutaneous Irreversible electroporation: Long-term survival analysis of 71 patients with inoperable malignant hepatic tumors. Sci Rep. 2017 Mar 7;7:43687. DOI:10.1038/srep43687; Scorseffi M, Comito T, Tozzi A, Navarria P, Fogliata A, Cleri-ci E, et al. Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer. J Cancer Res Clin Oncol. 2015 Mar;141 (3):543—53. doi:10.1007/s00432-014-1833-x; Mutsaers A, Greenspoon J, Walker-Dilks C, Swaminath A. Systematic review of patient reported quality of life following stereotactic ablative radiotherapy for primary and metastatic liver cancer. Radiat Oncol. 2017 Jun 29;12 (1):110. DOI:10.1186/s13014-017-0818-8.; Liu X, Song Y, Liang P, Su T, Zhang H, Zhao X, et al. Analysis of the factors affecting the safety of robotic stereotactic body radiation therapy for hepatocellular carcinoma patients. Onco Targets Ther. 2017 Nov 6;10:5289-5295. DOI:10.2147/OTT.S142025.; Moore A, Cohen-Naftaly M, Tobar A, Kundel Y, Benjaminov O, Braun M, et al. Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma. Radiat Oncol. 2017 Oct 19;12 (1):163. DOI:10.1186/s13014-017-0899-4; Деньгина Н. В., Мозерова Е. Я. Стереотаксическая лучевая терапия и локальная гипертермия в лечении опухолей различных локализаций. Практическая онкология. 2015;16 (4):162-173./Dengina NV, Mozerova EYa. Stereotactic body radiotherapy and local hyperthermia in the treatment of various malignant tumors. Practical Oncology. 2015;16 (4):162-173 (In Russian).; Kim TH, Park J-W, Kim BH, Kim DY, Moon SH, Kim SS, et al. Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma. Oncotarget. 2017 Dec 19;9 (3):4034-4043. DOI:10.18632/oncotarget.23428.; Mendez Romero A, Keskin-Cambay F, van Os RM, Nuyt-tens JJ, Heijmen BJM, IJzermans JNM, Verhoef C. Institutional experience in the treatment of colorectal liver metastases with stereotactic body radiation therapy. Rep Pract Oncol Radiother. 2017 Mar-Apr;22 (2):126-131. DOI:10.1016/j.rpor.2016.10.003; Mahadevan A, Blanck O, Lanciano R, Peddada A, Sundar-araman S, D'Ambrosio D, et al. Stereotactic Body Radiotherapy (SBRT) for liver metastasis — clinical outcomes from the international multi-institutional RSSearch® Patient Registry. Radiat Oncol. 2018 Feb 13;13 (1):26. DOI:10.1186/s13014-018-0969-2.; https://www.rpmj.ru/rpmj/article/view/322

Availability: https://www.rpmj.ru/rpmj/article/view/322
https://doi.org/10.17709/2409-2231-2018-5-4-6

THE POSSIBILITIES OF MODERN METHODS OF ABLATION IN NON-RESECTABLE LOCALLY ADVANCED PANCREATIC CANCER ; ВОЗМОЖНОСТИ СОВРЕМЕННЫХ МЕТОДОВ АБЛЯЦИИ ПРИ НЕРЕЗЕКТАБЕЛЬНОМ МЕСТНО-РАСПРОСТРАНЕННОМ РАКЕ ПОДЖЕЛУДОЧНОЙ ЖЕЛЕЗЫ

Authors: L. I. Moskvicheva, L. O. Petrov, D. V. Sidorov, Л. И. Москвичева, Л. О. Петров, Д. В. Сидоров

Source: Research and Practical Medicine Journal; Том 5, № 2 (2018); 86-99 ; Research'n Practical Medicine Journal; Том 5, № 2 (2018); 86-99 ; 2410-1893 ; 10.17709/2409-2231-2018-5-2

Subject Terms: фотодинамическая терапия, radiofrequency ablation, microwave ablation, high intensity focused ultrasound therapy, cryoablation, irreversible electroporation, stereotactic body radiotherapy, photodynamic therapy, радиочастотная абляция, микроволновая абляция, высокоинтенсивная фокусированная ультразвуковая терапия, криоабляция, необратимая электропорация, стереотаксическая лучевая терапия

File Description: application/pdf

Relation: https://www.rpmj.ru/rpmj/article/view/272/244; Состояние онкологической помощи населению России в 2016 году. Под редакцией Каприна А.Д., Старинского В.В., Петровой Г.В. М.: МНИОИ им. П. А. Герцена – филиал ФГБУ “ФМИРЦ” Минздрава России. 2017.; Камарли З.П., Туманбаев А.М., Доолотбеков С.М. Рак поджелудочной железы: эпидемиология, клиника, диагностика, лечение. Вестник КРСУ. 2013;13(1):117-122.; Котельников А.Г., Патютко Ю.И., Трякин А.А. Клинические рекомендации по диагностике и лечению злокачественных опухолей поджелудочной железы. Общероссийский союз общественных объединений Ассоциация онкологов России, 2014. с. 28.; Макаров Е.С., Нечушкин М.И. Современные возможности лучевоголеченияракаоргановбилиопанкреатодуоденальной зоны. Практическая онкология. 2004;5(2):135-144.; Girelli R, Frigerio I, Giardino A, Regi P, Gobbo S, Malleo G, et al. Results of 100 pancreatic radiofrequency ablations in the context of a multimodal strategy for stage III ductal adenocarcinoma. Langenbecks Arch Surg. 2013 Jan;398(1):63-9. DOI:10.1007/s00423-012-1011-z; Liu Q, Zhai B, Yang W, Yu LX, Dong W, He YQ, et al. Abrogation of local cancer recurrence after radiofrequency ablation by dendritic cell-based hyperthermic tumor vaccine. Mol Ther. 2009 Dec;17(12):2049-57. DOI:10.1038/mt.2009.221.; Zerbini A, Pilli M, Laccabue D, Pelosi G, Molinari A, Negri E, et al. Radiofrequency thermal ablation for hepatocellular carcinoma stimulates autologous NK-cell response. Gastroenterology. 2010 May;138(5):1931-42. DOI:10.1053/j.gastro.2009.12.051; Shah DR, Green S, Elliot A, McGahan JP, Khatri VP. Current oncologic applications of radiofrequency ablation therapies. World J Gastrointest Oncol. 2013;5:71-80. https://doi.org/10.4251/wjgo.v5.i4.71; Paiella S, Salvia R, Girelli R, Frigerio I, Giardino A, D’Onofrio M, et al. Role of local ablative techniques (Radiofrequency ablation and Irreversible Electroporation) in the treatment of pancreatic cancer. Updates Surg. 2016 Sep;68(3):307-311. DOI:10.1007/s13304-016-0385-9; Kallis Y, Phillips N, Steel A, Kaltsidis H, Vlavianos P, Habib N, Westaby D. Analysis of endoscopic radiofrequency ablation of biliary malignant strictures in pancreatic cancer suggests potential survival benefit. Dig Dis Sci. 2015 Nov;60(11):3449-55. doi:10.1007/s10620-015-3731-8.; Wu TT, Li HC, Li WM, Ao GK, Lin H, Zheng F, Song JY. Percutaneous Intraluminal Radiofrequency Ablation for Malignant Extra hepatic Biliary Obstruction: A Safe and Feasible Method. Dig Dis Sci. 2015;60(7):2158-63. Dig Dis Sci. 2015 Jul;60(7):2158-63. DOI:10.1007/s10620-015-3547-6; Wang J, Zhao L, Zhou C, Gao K, Huang Q, Wei B, Gao J. Percutaneous Intraductal Radiofrequency Ablation Combined with Biliary Stent Placement for Nonresectable Malignant Biliary Obstruction Improves Stent Patency but not Survival. Medicine (Baltimore). 2016 Apr;95(15):e3329. DOI:10.1097/MD.0000000000003329.; Rustagi T, Chhoda A. Endoscopic Radiofrequency Ablation of the Pancreas. Dig Dis Sci. 2017 Apr;62(4):843-850. DOI:10.1007/s10620-017-4452-y; Song TJ, Seo DW, Lakhtakia S, Reddy N, Oh DW, Park DH, et al. Initial experience of EUS guided radiofrequency ablation of unresectable pancreatic cancer. Gastrointest Endosc. 2016 Feb;83(2):440-3. DOI:10.1016/j.gie.2015.08.048; Pai M, Habib N, Senturk H, Lakhtakia S, Reddy N, Cicinnati VR, et al. Endoscopic ultrasound guided radiofrequency ablation, for pancreatic cystic neoplasms andneuroendocrine tumors. World J Gastrointest Surg. 2015 Apr 27;7(4):52-9. DOI:10.4240/ wjgs.v7.i4.52.; Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, et al. Image guided tumor ablation: standardization of terminology and reporting criteria – a 10-year update. J Vasc Interv Radiol. 2014 Nov;25(11):1691-705.e4. DOI:10.1016/j.jvir.2014.08.027; Lygidakis NJ, Sharma SK, Papastratis P, Zivanovic V, Kefalourous H, Koshariya M, et al. Microwave ablation in locally advanced pancreatic carcinoma – a new look. Hepatogastroenterology. 2007;54:1305–1310.; Carrafiello G, Ierardi AM, Fontana F, Petrillo M, Floridi C, Lucchina N, et al. Microwave ablation of pancreatic head cancer: safety and efficacy. J Vasc Interv Radiol. 2013 Oct;24(10):1513-20. DOI:10.1016/j.jvir.2013.07.005.; Van den Bijgaart RJE, Eikelenboom DC, Hoogenboom M, Fütterer JJ, den Brok MH, Gosse J. Thermal and mechanical high-intensity focused ultrasound: perspectives on tumor ablation, immune effects and combination strategies. J Vasc Interv Radiol. 2013 Oct;24(10):1513-20. DOI:10.1016/j.jvir.2013.07.005; Zhou Y. High-intensity focused ultrasound treatment for advanced pancreatic cancer. Gastroenterol Res Pract. 2014;2014:205325. DOI:10.1155/2014/205325.; Wu F. High intensity focused ultrasound: a noninvasive therapy for locally advanced pancreatic cancer. World J Gastroenterol. 2014 Nov 28;20(44):16480-8. DOI:10.3748/wjg.v20.i44.16480.; Diana M, Schiraldi L, Liu Y-Y, Memeo R, Mutter D, Pessaux P, Marescaux J. High intensity focused ultrasound (HIFU) applied to hepato-biliopancreatic and the digestive system – current state of the art and future perspectives. Hepatobiliary Surg Nutr. 2016 Aug;5(4):329-44. DOI:10.21037/hbsn.2015.11.03.; Wang K, Zhu H, Meng Z, Chen Z, Lin J, Shen Y, Gao H. Safety evaluation of high intensity focused ultrasound in patients with pancreatic cancer. Onkologie. 2013;36:88-92. DOI:10.1159/000348530; Sung HY, Jung SE, Cho SH, Zhou K, Han JY, Han ST, et al. Long-term outcome of high-intensity focused ultrasound in advanced pancreatic cancer. Pancreas. 2011;40(7):1080-1086. DOI:10.1097/mpa.0b013e31821fde24; Orsi F, Zhang L, Arnone P, Orgera G, Bonomo G, Vigna PD, et al. High-intensity focused ultrasound ablation: effective and safe therapy for solid tumors in difficult locations. AJR Am J Roentgenol. 2010 Sep;195(3):W245-52. DOI:10.2214/AJR.09.3321.; Gao HF, Wang K, Meng ZQ, Chen Z, Lin JH, Zhou ZH, et al. High intensity focused ultrasound treatment for patients with local advanced pancreatic cancer. Hepatogastroenterology. 2013 Nov-Dec;60(128):1906-10. DOI:10.5754/hge13498; Wang K, Chen Z, Meng Z, Lin J, Zhou Z, Wang P, et al. Analgesic effect of high intensity focused ultrasound therapy for unresectable pancreatic cancer. Int J Hyperthermia. 2011;27(2):101-7. DOI:10.3109/02656736.2010.525588.; Li PZ, Zhu SH, He W, Zhu LY, Liu SP, Liu Y, et al. High-intensity focused ultrasound treatment for patients with unresectable pancreatic cancer. Hepatobiliary Pancreat Dis Int. 2012;11(6):655-60. DOI:10.1016/s1499-3872(12)60241-0; Xiong LL, Hwang JH, Huang XB, Yao SS, He CJ, Ge XH, et al. Early clinical experience using high intensity focused ultrasound for palliation of inoperable pancreatic cancer. JOP. 2009;10(2):123-9.; Li T, Wang YN, Khokhlova TD, D’Andrea S, Starr F, Chen H, et al. Pulsed high intensity focused ultrasound (pHIFU) enhances delivery of doxorubicin in a preclinical model of pancreatic cancer. Cancer Res. 2015 Sep 15;75(18):3738-46. DOI:10.1158/00085472.CAN-15-0296; Lau PC-P, Zheng SF, Ng WT, Yu SC-H. Inoperable pancreatic adenocarcinoma rendered complete remission by high-intensity focused ultrasound concurrent with gemcitabine-capecitabine chemotherapy: Case report and topic review. J Dig Dis. 2012 Jan;13(1):60-4. DOI:10.1111/j.1751-2980.2011.00546.x; Zhao J, Zhao F, Shi Y, Deng Y, Hu X, Shen H. The efficacy of a new high intensity focused ultrasound therapy for locally advanced pancreatic cancer. J Cancer Res Clin Oncol. 2017 Oct;143(10):2105-2111. DOI:10.1007/s00432-017-2459-6.; Ханевич М.Д., Манихас Г.М. Криохирургия рака поджелудочной железы. СПб.: «Аграф+», 2011, 226 с.; Goel R, Anderson K, Slaton J, Schmidlin F, Vercellotti G, Belcher J, Bischof JC. Adjuvant approaches to enhance cryosurgery. J Biomech Eng. 2009 Jul;131(7):074003. DOI:10.1115/1.3156804; Rombouts SJE, Vogel JA, van Santvoort HC, van Lienden KP, van Hillegersberg R, Busch OR, et al. Systematic review of innovative ablative therapies for the treatment of locally advanced pancreatic cancer. Br J Surg. 2015 Feb;102(3):182-93. DOI:10.1002/bjs.9716.; Xu K, Niu L, Yang D. Cryosurgery for pancreatic cancer. Gland Surg. 2013;2:30-39. Gland Surg. 2013 Feb;2(1):30-9. DOI:10.3978/j.issn.2227-684X.2013.02.02; Niu L, Chen J, He L, Liao M, Yuan Y, Zeng J, et al. Combination treatment with comprehensive cryoablation and immunotherapy in metastatic pancreatic cancer. Pancreas. 2013 Oct;42(7):11439. DOI:10.1097/MPA.0b013e3182965dde.; He L, Niu L, Korpan NN, Sumida S, Xiao Y, Li J, et al. Clinical Practice Guidelines for Cryosurgery of Pancreatic Cancer. Pancreas. 2017 Sep;46(8):967-972. DOI:10.1097/MPA.0000000000000878.; Патютко Ю.И., Подлужный Д.В., Котельников А.Г., Сагайдак И.В. Криохирургический метод в лечении больных злокачественными опухолями поджелудочной железы. РАМН, Хирургическое отделение опухолей печени и поджелудочной железы. 2005 г. / Patyutko UI, Podluzhny DV, Kotelnikov AG, Sagaydak IV. Cryosurgical method in the treat; Li J, Chen X, Yang H, Wang X, Yuan D, Zeng Y, et al. Tumour cryoablation combined with palliative bypass surgery in the treatment of unresectable pancreatic cancer: a retrospective study of 142 patients. Postgrad Med J. 2011 Feb;87(1024):89-95. DOI:10.1136/pgmj.2010.098350; Al-Sakere B, Andre F, Bernat C, Connault E, Opolon P, Davalos RV, et al. Tumor ablation with irreversible electroporation. PloS one. 2007;2:1135. DOI:10.1371/journal.pone.0001135; Edelblute CM, Hornef J, Burcus NI, Norman T, Beebe SJ, Schoenbach K, et al. Controllable Moderate Heating Enhances the Therapeutic Efficacy of Irreversible Electroporation for Pancreatic Cancer. Sci Rep. 2017 Sep 18;7(1):11767. DOI:10.1038/ s41598-017-12227-4.; Wendler JJ, Fischbach K, Ricke J, Jürgens J, Fischbach F, Köllermann J, et al. Irreversible Electroporation (IRE): Standardization of Terminology and Reporting Criteria for Analysis and Comparison. Pol J Radiol. 2016 Feb 17;81:54-64. DOI:10.12659/ PJR.896034; Martin RC. Irreversible Electroporation of Locally Advanced Pancreatic Head Adenocarcinoma. J Gastrointest Surg. 2013 Oct;17(10):1850-6. DOI:10.1007/s11605-013-2309-z; Månsson C, Bergenfeldt M, Brahmstaedt R, Karlson B-M., Nygren P, Nilsson A. Safety and preliminary efficacy of ultrasound-guided percutaneous irreversible electroporation for treatment of localized pancreatic cancer. Anticancer Res. 2014 Jan;34(1):289-93.; Paiella S, Butturini G, Frigerio I, Salvia R, Armatura G, Bacchion M, et al. Safety and feasibility of Irreversible Electroporation (IRE) in patients with locally advanced pancreatic cancer: results of a prospective study. DigSurg. 2015;32(2):90–97. Dig Surg. 2015;32(2):90-7. DOI:10.1159/000375323.; Månsson C, Brahmstaedt R, Nilsson A, Nygren P, Karlson B-M. Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy. Eur J Surg Oncol. 2016 Sep;42(9):1401-6. DOI:10.1016/j.ejso.2016.01.024; Vogel JA, Rombouts SJ, van Delden OM, Dijkgraaf MG, van Gulik TM, van Hooft JE, et al. Induction chemotherapy followed by resection or irreversible electroporation in locally advanced pancreatic cancer (IMPALA): A prospective cohort study. J Cancer Res Clin Oncol. 2017 Dec;143(12):2607-2618. doi:10.1007/s00432-017-2513-4; Lin M, Liang S, Wang X, Liang Y, Zhang M, Chen J, et al. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment. J Cancer Res Clin Oncol. 2017 Dec;143(12):2607-2618. DOI:10.1007/s00432-017-2513-4; Belfiore MP, Ronza FM, Romano F, PietroIanniello G, Lucia GD, Gallo C, et al. Percutaneous CT-guided irreversible electroporation followed by chemotherapy as a novel neoadjuvant protocol in locally advanced pancreatic cancer: Our preliminary experience. Int J Surg. 2015 Sep;21 Suppl 1:S34-9. DOI:10.1016/j.ijsu.2015.06.049; Деньгина Н.В., Родионов В.В. Основы лучевой терапии злокачественных новообразований: учебно-методическое пособие для врачей и студентов. Ульяновск: УлГУ, 2013. 87 с.; Zhu X, Ju X, Cao F, Fang F, Qing S, Shen Y, et al. Safety and efficacy of stereotactic body radiation therapy combined with S-1 simultaneously followed by sequential S-1 as an initial treatment for locally advanced pancreatic cancer (SILAPANC) trial: study design and rationale of a phase II clinical trial. BMJ Open. 2016 Dec 1;6(12):e013220. DOI:10.1136/bmjopen-2016-013220.; Brunner T., Nestle U., Grosu A., Partridge M. SBRT in pancreatic cancer: what is the therapeutic windows? Radiother Oncol. 2015 Jan;114(1):109-16. DOI:10.1016/j.radonc.2014.10.015; Деньгина Н.В., Мозерова Е.Я. Стереотаксическая лучевая терапия и локальная гипертермия в лечении опухолей различных локализаций. Практическая онкология. 2015;16(4):162-73.; Mellon EA, Hoffe SE, Springett GM, Frakes JM, Strom TJ, Hodul PJ, et al. Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma. Acta Oncol. 2015 Jul;54(7):979-85. DOI:10.3109/0284186X.2015.1004367; Zhu X, Li F, Ju X, Cao F, Cao Y, Fang F, et al. Prognostic role of stereotactic body radiation therapy for elderly patients with advanced and medically inoperable pancreatic cancer. Cancer Med. 2017 Oct;6(10):2263-2270. DOI:10.1002/cam4.1164; Dagoglu N, Callery M, Moser J, Tseng J, Kent T, Bullock A, et al. Stereotactic Body Radiotherapy (SBRT) Reirradiation for Recurrent Pancreas Cancer. J Cancer. 2016 Jan 10;7(3):283-8. DOI:10.7150/jca.13295.; Bown SG, Rogowska AZ, Whitelaw DE, Lees WR, Lovat LB, Ripley P, et al. Photodynamic therapy for cancer of the pancreas. Gut. 2002;50:549-557. https://doi.org/10.1136/gut.50.4.549; Huggett MT, Jermyn M, Gillams A, Illing R, Mosse S, Novelli M, et al. Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer. Br J Cancer. 2014 Apr 2;110(7):1698-704. DOI:10.1038/bjc.2014.95; https://www.rpmj.ru/rpmj/article/view/272

Availability: https://www.rpmj.ru/rpmj/article/view/272
https://doi.org/10.17709/2409-2231-2018-5-2-10

Контроль эффективности электропорации с помощью измерения проводимости тканей

Contributors: Алейник, Александр Никонорович

Subject Terms: электропорация, электрический ток, мембраны, электрические импульсы, липиды

Access URL: http://earchive.tpu.ru/handle/11683/41463

Исследование экстракции веществ под действием импульсного электрического поля

Contributors: Юдин, Артём Сергеевич

Subject Terms: электропорация, растительное сырье, полезные компоненты, электрическое поле, межэлектродные промежутки

Access URL: http://earchive.tpu.ru/handle/11683/41466

МОДЕЛИРОВАНИЕ И АНАЛИЗ ПАРАМЕТРОВ ЭЛЕКТРОПОРАЦИИ МЕМБРАНЫ БИОЛОГИЧЕСКОЙ КЛЕТКИ В ИМПУЛЬСНОМ ЭЛЕКТРИЧЕСКОМ ПОЛЕ С ИЗМЕНЯЕМОЙ НАПРЯЖЕННОСТЬЮ

Authors: Shigimaga, V. A., Megel, Yu. Ye., Kovalenko, S. V., Kovalenko, S. M.

Source: Radio Electronics, Computer Science, Control; № 4 (2017): Radio Electronics, Computer Science, Control; 57-65
Радиоэлектроника, информатика, управление; № 4 (2017): Радиоэлектроника, информатика, управление; 57-65
Радіоелектроніка, iнформатика, управління; № 4 (2017): Радіоелектроніка, інформатика, управління; 57-65

Subject Terms: Імпульсне електричне поле, напруженість, електропорація, мембрана, біологічна клітина, моделювання, алгоритм, апроксимація, поліном, Импульсное электрическое поле, напряженность, электропорация, биологическая клетка, моделирование, аппроксимация, полином, Pulse electric field, intensity, electroporation, membrane, biological cell, modeling, algorithm, approximation, polynomial

File Description: application/pdf

Access URL: http://ric.zntu.edu.ua/article/view/126187

Електропорація як спосіб лікування проблем шкіри

Contributors: ELAKPI

Subject Terms: electroporation, электропорация, електропорація, косметология, cosmetology, безін'єкційна мезотерапія, безинъекционная мезотерапия, косметологія, noninjection mesotherapy

File Description: application/pdf

Access URL: https://ela.kpi.ua/handle/123456789/33648

TRANSDERMAL DRUG DELIVERY AND METHODS TO ENHANCE IT ; ТРАНСДЕРМАЛЬНЫЙ ПЕРЕНОС ЛЕКАРСТВЕННЫХ ВЕЩЕСТВ И СПОСОБЫ ЕГО УСИЛЕНИЯ

Authors: E. G. Kuznetsova, V. A. Ryzhikova, L. A. Salomatina, V. I. Sevastianov, Е. Г. Кузнецова, В. А. Рыжикова, Л. А. Саломатина, В. И. Севастьянов

Contributors: Министерство здравоохранения Российской Федерации

Source: Russian Journal of Transplantology and Artificial Organs; Том 18, № 2 (2016); 152-162 ; Вестник трансплантологии и искусственных органов; Том 18, № 2 (2016); 152-162 ; 1995-1191 ; 10.15825/1995-1191-2016-2

Subject Terms: холодная плазма, transdermal drug delivery system, transfer activator, iontophoresis, sonophoresis, electroporation, cold plasma, трансдермальная терапевтическая система, активатор переноса, ионофорез, сонофорез, электропорация

File Description: application/pdf

Relation: https://journal.transpl.ru/vtio/article/view/650/551; Hupfeld S, Gravem H. Transdermal therapeutic systems for drug administration. Tidsskr Nor Laegeforen. 2009; 129 (6): 532–533.; Farlow MR, Somogyi M. Transdermal patches for the treatment of neurologic conditions in elderly patients: a review. Prim Care Companion CNS Disord. 2011; 13 (6). doi:10.4088/PCC.11r01149.; Мизина ПГ, Быков ВА, Настина ЮИ, Фоменко ЕА. Введение лекарственных веществ через кожу – достижения и перспективы (обзор). Вестник ВГУ. Сер.: Химия. Биология. Фармация. 2004; 176–183. Mizina PG, Bykov VA, Nastina JuI, Fomenko EA. Vvedenie lekarstvennyh veshchestv cherez kozhu – dostizhenija i perspektivy (obzor). Vestnik VGU. Ser.: Himija. Biologija. Farmacija. 2004; 176–183.; Севастьянов ВИ, СаломатинаЛА, Тихобаева АА и др. Трансдермальные терапевтические системы. Биосовместимые материалы (учебное пособие). Под ред. В.И. Севастьянова и М.П. Кирпичникова. Часть III, глава 2. М.: МИА, 2011; 309. Sevast’janov VI, Salomatina LA, Tihobaeva AA i dr. Transdermal’nye terapevticheskie sistemy. Biosovmestimye materialy (uchebnoe posobie). Pod red. V.I. Sevast’janova i M.P. Kirpichnikova. Chast’ III, glava 2. M.: MIA, 2011; 309.; Береговых ВВ, Пятигорская НВ, Прудкевич ЮА и др. Трансдермальные терапевтические системы доставки лекарственных средств. Вестник МИТХТ. 2012; 7 (5): 17–22. Beregovyh VV, Pjatigorskaja NV, Prudkevich JuA i dr. Transdermal’nye terapevticheskie sistemy dostavki lekarstvennyh sredstv. Vestnik MITHT. 2012; 7 (5): 17–22.; N’Da DD. Prodrug strategies for enhancing the percutaneous absorption of drugs. Molecules. 2014; 19 (12): 20780–20807. doi:10.3390/molecules191220780.; Asbrill CS, EL-Kattan AF, Marchiniak B. Enchancement of transdermal drug delivery: chemical and physical approaches. Crit Rev Ther Drug Carrier Syst. 2000; 17 (6): 612–658.; Naik A, Kalia YN, Guy RH. Transdermal drug delivery: overcoming the skin´s barrier function. Pharm. Sci / Technolo. Today. 2000; 3(9): 318–326.; Задымова НМ. Коллоидно-химические аспекты трансдермальной доставки лекарств (обзор). Коллоидный журнал. 2013; 75 (5): 543–556. Zadymova NM. Kolloidno-himicheskie aspekty transdermal’noj dostavki lekarstv (obzor). Kolloidnyj zhurnal. 2013; 75 (5): 543–556.; Ashok K. Tiwary, Bharti Sapra, Subheet Jain. Innovations in Transdermal Drug Delivery: Formulations and Techniques. Recent Patents on Drug Delivery and Formulation. 2007; 1: 23–36.; Пат. 2465848 Российская Федерация, А61М25, А61В17/20. Способ и аппарат для образования нескольких микроканалов / Xерндон Терри O.; патентообладатель Пат сайнтифик, ллк. (US) – заявка 2009144762; опубл. 10.11.2012. Xerndon Terri O. Sposob i apparat dlja obrazovanija neskol’kih mikrokanalov [Method and apparatus for forming multiple microchannels] Patent RF, no. 2465848, 2012.; Subedi RK, Oh SY, Chun MK, Choi HK. Recent advances in transdermal drug delivery. Arch Pharm Res. 2010; 33 (3): 339–351. doi:10.1007/s12272-010-0301-7.; Sugino M, Todo H, Sugibayashi K. Skin permeation and transdermal delivery systems of drugs: history to overcome barrier function in the stratum corneum. Yakugaku Zasshi. 2009; 129 (12): 1453–1458.; Parhi R, Suresh P, Patnaik S. Physical means of stratum corneum barrier manipulation to enhance transdermal drug delivery. Curr Drug Deliv. 2014. doi:10.2174/1567 201811666140515145329.; Paudel KS, Milewski M, Swadley CL. Challenges and opportunities in dermal/transdermal delivery. Ther Deliv. 2010; 1 (1): 109–131.; Karande P, Mitragotri S. Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim Biophys Acta. 2009; 1788 (11): 2362–2373. doi:10.1016/j.bbamem.2009.08.015.; Benson HA. Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliv. 2005; 2 (1): 23–33.; Ahad A, Aqil M, Kohli K (et al). Chemical penetration enhancers: a patent review. Expert Opin Ther Pat. 2009; 19 (7): 969–988. doi:10.1517/13543770902989983.; Aggarwal G, Dhawan S, HariKumar SL. Natural oils as skin permeation enhancers for transdermal delivery of olanzapine: in vitro and in vivo evaluation. Curr Drug Deliv. 2012; 9 (2): 172–181.; Wohlrab J, Kreft B, Tamke B. Skin tolerability of transdermal patches. Expert Opin Drug Deliv. 2011; 8 (7): 939–948.; Kogan A, Garti N. Microemulsions as transdermal drug delivery vehicles. Adv Colloid Interface Sci. 2006; 123– 126: 369–385.; Lopes LB. Overcoming the cutaneous barrier with microemulsions. Pharmaceutics. 2014; 6 (1): 52–77. doi:10.3390/pharmaceutics6010052.; Otto A, du Plessis J, Wiechers JW. Formulation effects of topical emulsions on transdermal and dermal delivery. Int J Cosmet Sci. 2009; 31 (1): 1–19. doi:10.1111/j.14682494.2008.00467.x.; Heuschkel S, Goebel A, Neubert RH. Microemulsionsmodern colloidal carrier for dermal and transdermal drug delivery. J Pharm Sci. 2008; 97 (2): 603–631.; Date AA, Patravale VB. Microemulsions: applications in transdermal and dermal delivery. Crit Rev Ther Drug Carrier Syst. 2007; 24 (6): 547–596.; Azeem A, Khan ZI, Aqil M, Ahmad FJ, Khar RK, Talegaonkar S. Microemulsions as a surrogate carrier for dermal drug delivery. Drug Dev Ind Pharm. 2009; 35 (5): 525–547. doi:10.1080/03639040802448646.; Кузнецова ЕГ, Курылева ОМ, Саломатина ЛА, Севастьянов ВИ. Матричные трансдермальные системы доставки кофеина на основе полимерной и эмульсионной композиций. Медицинская техника. 2008; 3: 33–35. Kuznetsova EG, Kuryleva OM, Salomatina LA, Sevast’yanov VI. Matrix transdermal systems for coffeine delivery based of polymer aтв emulsion compounds. Journal Biomedical Engineering. 2008; 42 (3): 141–144. [English abstract].; Севастьянов ВИ, Саломатина ЛА, Кузнецова ЕГ, Собко ОМ, Шумаков ВИ. Матричные и резервуарные трансдермальные терапевтические системы инсулина на основе нетканых и полимерных материалов. Перспективныематериалы. 2004; 4: 44–48. Sevast’janov VI, Salomatina LA, Kuznetsova EG, Sobko OM, Shumakov VI. Matrichnye i rezervuarnye transdermal’nye terapevticheskie sistemy insulina na osnove netkanyh i polimernyh materialov. Perspektivnye materialy. 2004; 4: 44–48.; Севастьянов ВИ, Саломатина ЛА, Кузнецова ЕГ, Серегина МВ, Басок ЮБ. Трансдермальная лекарственная форма ацизола – антидота угарного газа. Перспективные материалы. 2008; 6: 55–59. Sevast’janov VI, Salomatina LA, Kuznetsova EG, Seregina MV, Basok JuB. Transdermal’naja lekarstvennaja forma acizola – antidota ugarnogo gaza. Perspektivnye materialy. 2008; 6: 55–59.; Рыжикова ВА. Трансдермальная терапевтическая система бромокаина на основе биосовместимой микроэмульсионной композиции: дис. … канд биол. наук. М., 2015: 108. Ryzhikova VA. Transdermal’naja terapevticheskaja sistema bromokaina na osnove biosovmestimoj mikrojemul’sionnoj kompozicii [Dissertation]. М., 2015:108.; Кравченко ИА, Андронати СА, Ларионов ВБ. Физико-химические основы усиления трансдермального введения лекарственных. О.: Астропринт, 2002: 224. Kravchenko IA, Andronati SA, Larionov VB. Fiziko-himicheskie osnovy usilenija transdermal’nogo vvedenija lekarstvennyh. O.: Astroprint, 2002: 224.; Vulta NB, Betageri, GV, Banga AK. Transdermal iontophoretic delivery of enkephalin formulated in liposomes. J Pharm. Sci. 1996; 85 (1): 5–8.; Banga AK, Bose S, Ghosh TK. Iontophoresis and electroporation: comparisons and contrasts. Int J Pharm. 1999; 179: 1–19.; Fang JY, Sung KC, Lin HH, Fang CL. Transdermal iontophoretic delivery of enoxacin from various liposomeencapsulated formulations. J Control Release. 1999; 60: 1–10.; Han I, Kim M, Kim J. Enhanced transfollicular delivery of adriamycin with a liposome and iontophoresis. Exp Dermatol. 2004; 13 (2): 86–92.; Smith NB. Perspectives on transdermal ultrasound mediated drug delivery. International Journal of Nanomedicine. 2007; 4 (V.2): 585–594.; Кравченко ИА, Михайлова ТВ, Скипа МИ. Ультразвук в усилении трансдермального введения лекарственных препаратов. Актуальные проблемы транспортной медицины. 2011; 2 (24): 13–22. Kravchenko IA, Mihajlova TV, Skipa MI. Ul’trazvuk v usilenii transdermal’nogo vvedenija lekarstvennyh preparatov. Aktual’nye problemy transportnoj mediciny. 2011; 2 (24): 13–22.; Weimann et al. Metod and apparatus for in vivo transdermal and/or intradermal delivery of drugs by sonoporation // Patent USA no. 6487447. 2002.; Bommannan et al. Ultrasound-enhanced delivery of materials into and though the skin // Patent USA no. 5323769. 1994.; Rowe et al. Ultrasound enhancement of transdermal transport // Patent USA no. 6234990. 2001.; McDaniel. Ultrasound enhancement of percutaneous drug absorption // Patent USA no. 7004933. 2006.; Acano J, Suisha F, Takada M et al. Effect of pulsed output ultrasound on the transdermal absorption of indomethacin from an ointment in rats. Biol Pharm Bull. 1997; 20: 288–291.; Weimann et al. Metod and apparatus for intradermal incorporation of microparticles containing incapsulated drug low frequency ultrasound enhance transdermal delivery // Patent USA no. 6712805. 2004.; Mitragotri et al. Transdermal delivery of encapsulated drugs // Patent USA no. 675814599. 1998.; Eppstein JA, Delcer NK, Hatch MR. Insylin infusion with Micropor peptide and protein delivery system. Altea Development Corporation. 2000.; Weimann. Intradermal incorporation of microparticles containing encapsulated drugs using low frequency ultrasound // Patent USA no. 7232431. 2007.; Teruel MN, Blanpied TA, Shen K, Augustine GJ, Mayer T. A versatile microporation technique for the transfection of cultured CNS neutons. Neurosci methods. 1999; 93 (1): 37–48.; Denet AR, Vanbeer R, Preat V. Skin electroporation for transdermal and topical delivery. Adv. Drug Deliv Rev. 2004; 56 (5): 659–674.; Badkar AV, Betagen GV, Hofmann GA, Banga AK. Enchancement of transdermal iontophoretic delivery of a liposomal formulation of colchicines by electroporation. Drug Deliv. 1999; 6: 111–115.; Lan CY, Tan PH, Cheng JT, Lu HF, Lin MW, Hsiao PN et al. Immunoneutralization of c-Fos using intrathecal antibody electroporation attenuates chronic constrictive injury-induced hyperalgesia and regulates prepodynorphin expression in rats. Anesthesiology. 2003; 99 (4): 938–946.; Hyacinthe M, Jaroszeski MJ, Dang VV, Copola D, Karl RC, Gilbert RA et al. Electrically enhanced drug delivery for the treatment of soft tissue sarcoma. Cancer. 1999; 85 (2): 409–417.; Jaroszelski MJ, Dang V, Pottinger C, Hickey J, Gilbert R, Heller R. Toxicity of anticancer agents mediated by electroporation in vitro. Anticancer Drugs. 2000; 11 (3): 201–208.; Mir LM, Glass LF, Sersa G, Teissie J, Domenge C, Miklavcic D et al. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer. 1998; 77 (12); 2336–2342.; Gehl J, Geertsen PF. Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy. Melanoma Res. 2000; 10 (6): 585–589.; Sersa G, Stabuc B, Cemazar M, Miklavcic D, Rudolf Z. Electrochemotherapy with cisplatin: the systemic antitumour effectiveness of cisplatin can be potentiated locally by the application of electric pulses in the treatment of malignant melanoma skin metastases. Melanoma Res. 2000; 10 (4): 381–385.; Vicente-Ortega V, Martinez C, Yanez J, Canteras-Jordana M. Мelanoma metastasico pulmonary: efectos del etanol y fl avonoides. Rev. Esp. patol. 2003; 36 (4): 425– 432.; Rubin E, Gorstein F, Schwarting R, Strayer DS. Cell injury. Strayer D, ed. Rubin’s Pathology. Philadephia: Lippincott Williams and Wolkins, 2005.; Li S, Xia X, Mellieon FM, Liu J, Steele S. Candidate genes associated with tumor regression mediated by intratumoral IL-12 electroporation gene therapy. Mol Ther. 2004; 9 (3): 347–354.; Dean DA. Electroporation of the vasculature and the lung. DNA Cell Biol. 2003; 22 (12): 797–806.; Li S, Benninger M. Applications of muscle electroporation gene therapy. Curr Gene Ther. 2002; 2 (1): 101–105.; Dayball K, Millar J, Miller M, Wan YH, Bramson J. Electroporation enables plasmid vaccines to elicit CD8 + T cell responses in the absence of CD4 + T cells. J Immunol. 2003; 171 (7): 3379–3384.; Davalos RV, Otten DM, Mir LM, Rubinsky B. Electrical impedance tomography for imaging tissue electroporation. IEEE Trans Biomed Eng. 2004; 51 (5): 761–767.; Морфологические и биохимические доказательства доставки макромолекул путем электропорации с помощью электромагнитных волн (TDES® – DERCONT DELL®). Университет Мурчии. URL: http://lib.znate.ru/docs/index-230073.html (дата обращения: 01.02.2016). Morfologicheskie i biohimicheskie dokazatel’stva dostavki makromolekul putem ehlektroporacii s pomoshch’yu ehlektromagnitnyh voln (TDES® – DERCONT DELL®). Universitet Murchii. URL: http://lib.znate.ru/docs/index-230073.html (data obrashcheniya: 01.02.2016).; Манешина ОА, Ерофеева СБ, Леонова МВ. Новые неинъекционные формы инсулинов. Лечебное дело. 2011; 3: 17–24. Maneshina OA, Erofeeva SB, Leonova MV. Novye neinekcionnye formy insulinov. Lechebnoe delo. 2011; 3: 17–24.; Birchall J, Coulman S, Anstey A, Gateley C, Sweetland H, Gershonowitz A, Neville L, Levin G. Cutaneous gene expression of plasmid DNA in excised human skin following delivery via microchannels created by radio frequency ablation. Int J Pharm. 2006; 7: 15–23.; Friedman G, Gutsol A, Shekhter AB, Vasilets VN, Fridman A. Applied plasma medicine. Plasma Process. Polym. 2008; 5: 503–533.; Moreau M, Orange N, Feuilloley MGJ. Non-thermal plasma technologies: new tools for biodecontamination. Biotechnol. Adv. 2008; 26: 610–617.; Kong MG, Kroesen G, Morfill G, van Dijk J, Nosenko T, Zimmermann JL, Shimizu T. Plasma medicine: an introductory review. New Journal of Physics. 2009; 11: 35.; Жданов СК, Курнаев ВА, Романовский МК, Цветков ИВ. Основы физических процессов в плазме и плазменных установках: Учебное пособие. М.: МИФИ, 2000: 184. Zhdanov SK, Kurnaev VA, Romanovskij MK, Cvetkov IV. Osnovy fizicheskih processov v plazme i plazmennyh ustanovkah: Uchebnoe posobie. M: MIFI, 2000: 184.; Deng S, Ruan R, Mok CK, Huang G, Lin X, Chen P. Inactivation of Escherichia coli on almonds using nonthermal plasma. J. Food Sci. 2007; 72: 62–66.; Deilmann M, Halfmann H, Bibinov N, Wunderlich J, Awakowicz P. Low-pressure microwave plasma sterilization of polyethylene terephthalate bottles. J. Food Prot. 2008; 71: 2119–2123.; Selcuk M, Oksuz L, Basaran P. Decontamination of grains and legumes infected with Aspergillus spp. and Penicillum spp. by cold plasma treatment. Bioresour. Technol. 2008; 99: 5104–5109.; Kalghatgi S, Antonakas DP, Tsai T-Ch, Gray RL et al. Transdermal delivery of DNA Vaccines using non-thermal plasma. Patent US no. 2015/0151135 А1.; Bauerova K, Matusova D, Kassai Z. Chemical enhancers for transdermal drug transport. Eur J Drug Metab Pharmacokinet. 2001; 26 (1–2): 85–94.; Lie´vin Daugimont, Nolwenn Baron, Gae¨lle Vandermeulen, Natasa Pavselj, Damijan Miklavcic, MarieCaroline Jullien et al. Hollow Microneedle Arrays for Intradermal Drug Delivery and DNA Electroporation. J Membrane Biol. 2010; 236: 117–125.; Chen MC, Ling M, Kusuma SJ. Poly-γ-glutamic acid microneedles with a supporting structure design as a potential tool for transdermal delivery of insulin. Acta Biomater. 2015; 24: 106–116.; Chanda Silpi, Bagga Manish, Tiwari Raj Kumar. Microneedles in transdermal drug delivery: an unique painless option. International research journal of pharmacy. 2011; 2 (4): 72–; 78. Bora P, Kumar L, Bansal A. Micronidle technology for advanced drug delivery: Evolving Vistas. CRIP. 2008; 9: 7–10.; Гоникова ЗЗ. Результаты предварительных исследований диффузии инсулина через перфорированную кожу кролика в условиях in vitro. Вестник Российского государственного медицинского университета. X Международная (XIX Всероссийская) Пироговская научная медицинская конференция студентов и молодых ученых. М., 19 марта 2015: 842. Gonikova ZZ Rezul’taty predvaritel’nyh issledovanij diffuzii insulina cherez perforirovannuju kozhu krolika v uslovijah in vitro. Vestnik Rossijskogo gosudarstvennogo medicinskogo universiteta. X Mezhdunarodnaja (XIX Vserossijskaja) Pirogovskaja nauchnaja medicinskaja konferencija studentov i molodyh uchenyh. M., 19 marta 2015: 842.; https://journal.transpl.ru/vtio/article/view/650

Availability: https://journal.transpl.ru/vtio/article/view/650
https://doi.org/10.15825/1995-1191-2016-2-152-162

Optimization of transfection for CFTE29o- cell culture to develop editing of F508del mutation in CFTR gene ; Оптимизация условий трансфекции клеточной культуры CFTE29o- для разработки редактирования мутации F508del в гене CFTR

Authors: S. A. Smirnikhina, A. V. Bannikov, A. V. Lavrov, С. А. Смирнихина, А. В. Банников, А. В. Лавров

Source: Medical Genetics; Том 15, № 8 (2016); 36-39 ; Медицинская генетика; Том 15, № 8 (2016); 36-39 ; 2073-7998

Subject Terms: Green Fluorescent Proteins, кальций-фосфатная трансфекция, липофекция, электропорация, GFP, CFTE29o -, Electroporation, Transfection, Gene Transfer Techniques

File Description: application/pdf

Relation: https://www.medgen-journal.ru/jour/article/view/163/151; Whiting P, Al M, Burgers L, et al. Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2014 Mar;18(18):1-106.; Mayer M. Lumacaftor-ivacaftor (Orkambi) for cystic fibrosis: behind the ‘breakthrough’. Evid Based Med. 2016 Jun;21(3):83-86.; Cholon DM, Esther CR Jr, Gentzsch M. Efficacy of lumacaftor-ivacaftor for the treatment of cystic fibrosis patients homozygous for the F508del-CFTR mutation. Expert Rev Precis Med Drug Dev. 2016;1(3):235-243.; Kim YG, Cha J, Chandrasegaran S. Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1156-1160.; Cermak T, Doyle EL, Christian M, et al. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res. 2011 Jul;39(12):e82.; Zhang F, Wen Y, Guo X. CRISPR/Cas9 for genome editing: progress, implications and challenges. Hum Mol Genet. 2014 Sep 15;23(R1):R40-46.; Ran FA, Hsu PD, Wright J, et al. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013 Nov;8(11):2281-2308.; Bobadilla JL, Macek M Jr, Fine JP, Farrell PM. Cystic fibrosis: a worldwide analysis of CFTR mutations-correlation with incidence data and application to screening. Hum Mutat. 2002 Jun;19(6):575-606.; Kaestner L, Scholz A, Lipp P. Conceptual and technical aspects of transfection and gene delivery. Bioorg Med Chem Lett. 2015 Mar 15;25(6):1171-1176.; Graham FL, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973 Apr;52(2):456-467.; Kunzelmann K, Schwiebert EM, Zeitlin PL, Kuo WL, Stanton BA, Gruenert DC. An immortalized cystic fibrosis tracheal epithelial cell line homozygous for the delta F508 CFTR mutation. Am J Respir Cell Mol Biol. 1993 May;8(5):522-529.

Availability: https://www.medgen-journal.ru/jour/article/view/163
https://doi.org/10.1234/XXXX-XXXX-2016-8-36-39

Scientific Practicum for Students of the Specialty «Medical Biophysics» ; НАУЧНЫЙ ПРАКТИКУМ ДЛЯ СТУДЕНТОВ ПО СПЕЦИАЛЬНОСТИ «МЕДИЦИНСКАЯ БИОФИЗИКА»

Authors: A. M. Chernysh, D. S. Belopakhov, A. A. Belyaevskaya, A. V. Zakaryan, M. S. Kupriyanova, M. A. Postnikov, E. V. Sergeenko, I. M. Shogenov, А. М. Черныш, Д. С. Белопахов, А. А. Белопахов, А. В. Закарян, М. С. Куприянова, М. А. Постников, Е. В. Сергеенко, И. М. Шогенов

Source: General Reanimatology; Том 12, № 4 (2016); 79-88 ; Общая реаниматология; Том 12, № 4 (2016); 79-88 ; 2411-7110 ; 1813-9779 ; 10.15360/1813-9779-2016-4

Subject Terms: спектрофотометрия, methodology of scientific experiment, atomic force microscopy, calibrated elec troporation, spectrophotometry, методология научного эксперимента, атомная силовая микроско пия, калиброванная электропорация

File Description: application/pdf

Relation: https://www.reanimatology.com/rmt/article/view/1542/1054; https://www.reanimatology.com/rmt/article/view/1542/1055; Kozlova E.K., Chernysh A.M., Moroz V.V., Kuzovlev A.N. Analysis of nanostructure of red blood cells membranes by space Fourier transform of AFM images. Micron. 2013; 44: 218—227. http://dx.doi.org/10.1016/j.micron.2012.06.012. PMID: 22854216; Костин А.И., Майорова О.А., Ложкин А.В., Почтарь М.Е., Демичева М.И., Кузмичев В.А., Луговская С.А., Наумова Е.В., Кисиличина Д.Г., Андрейцева Э.В., Долгов В.В. К вопросу о контроле качества эритроцитсодержащих компонентов крови, обедненных лейкоцитами. Трансфузиология. 2011; 12 (2): 12-33.; Berezina T.L., Zaets S.B., Morgan C., Spillert C.R., Kamiyama M., Spolarics Z., Deitch E.A., Machiedo G.W. Influence of storage on red blood cell rheological properties. J. Surg. Res. 2002; 102 (1): 6-12. http://dx.doi.org/10.1006/jsre.2001.6306. PMID: 11792145; Hess J.R., Sparrow R.L., van der Meer P.F., Acker J.P., Cardigan R.A., Devine D.V. Red blood cell hemolysis during blood bank storage: using national quality management data to answer basic scientific questions. Transfusion. 2009; 49 (12): 599-603. http://dx.doi.org/10.1111/j.1537-2995.2009.02275.x. PMID: 20163690; Мороз В.В., Голубев А.М., Черныш А.М., Козлова Е.К., Васильев В.Ю., Гудкова О.Е., Сергунова В.А., Фёдорова М.С. Изменения структуры поверхности мембран эритроцитов при длительном хранении донорской крови. Общая реаниматология. 2012; 8 (1): 5-13. http://dx.doi.org/10.15360/1813-9779-2012-1-5; Мороз В.В., Черныш А.М., Козлова Е.К., Сергунова В.А., ГудковаО.Е., Хорошилов С.Е., Онуфриевич А.Д., Костин А.И. Нарушения морфологии и наноструктуры мембран эритроцитов при длительном хранении эритроцитарной взвеси (исследование при помощи атомной силовой микроскопии). Бюл. эксперим. биологии и медицины. 2015; 159 (3): 390-394. http://dx.doi.org/10.1007/s10517-015-2975-9. PMID: 26212816; Kozlova E., Chernysh A., Moroz V., Sergunova V., Gudkova O., Kuzovlev A. Nanodefects of membranes cause destruction of packed red blood cells during long-termstorage. Exp. Cell Res. 2015; 337 (2): 192–201. http://dx.doi.org/10.1016/j.yexcr.2015.07.009. PMID: 26169694; Moroz V.V., Chernysh A.M., Kozlova E.K., Borshegovskaya P.Y., Bliznjuk U.A., Rysaeva R.M., Gudkova O.E. Comparison of red blood cell membrane microstructure after different physicochemical influences: atomic force microscope research. J. Crit. Care 2010; 25 (3): 539.e1—539.e12. http://dx.doi.org/10.1016/j.jcrc.2010.02.007. PMID: 20381299; Kozlova E., Chernysh A., Moroz V., Sergunova V., Gudkova O., Fedorova M., Kuzovlev A. Opposite effects of electroporation of red blood cell membranes under the influence of zinc ions. Acta Bioeng. Biomech. 2012; 14 (1): 3—13. PMID: 22741531; Kozlova E., Chernysh A., Moroz V., Gudkova O., Sergunova V., Kuzovlev A. Transformation of membrane nanosurface of red blood cells under hemin action. Sci. Rep. 2014; 4: 6033. http://dx.doi.org/10.1038/srep06033. PMID: 25112597; Черныш А.М., Козлова Е.К., Мороз В.В. Способ выявления повреждения мембран эритроцитов. Патент РФ на изобретение № 2487356.; Козлова Е.К., Черняев А.П., Алексеева П.Ю., Близнюк У.А., Черныш A.М., Назарова М.А. Диагностика состояния биологических мембран после воздействия г-излучения в малых дозах. Радиационная биология. Радиоэкология. 2005; 45 (6): 653—656. PMID: 16454330; Kozlova Е., Chernysh А., Moroz V., Sergunova V., Zavialova А., Kuzovlev А. Nanoparticles of perfluorocarbon emulsion contribute to the reduction of methemoglobin to oxyhemoglobin. Int. J. Pharm. 2016; 497 (1-2): 88-95. http://dx.doi.org/10.1016/j.ijpharm.2015.11.035. PMID: 26626224; Гудкова О.Е., Козлов А.П. Неоднородность распределения электрических трансмембранных потенциалов при дефибрилляции сердца. Общая реаниматология. 2015; 11 (6): 38-47. http://dx.doi.org/10.15360/1813-9779-2015-6; Сергунова В.А., Козлова Е.К., Мягкова Е.А., Черныш А.М. Измерение упруго-эластичных свойств мембраны нативных эритроцитов in vitro. Общая реаниматология. 2015; 11 (3): 39#44. http://dx.doi.org/10.15360/1813-9779-2015-3-39-44; Перепелица С.А., Сергунова В.А., Гудкова О.Е., Алексеева С.В. Особенности мембран эритроцитов недоношенных новорожденных при многоплодной беременности. Общая реаниматология. 2014; 10 (1): 12-24. http://dx.doi.org/10.15360/1813-9779-2014-12-24; https://www.reanimatology.com/rmt/article/view/1542

Availability: https://www.reanimatology.com/rmt/article/view/1542
https://doi.org/10.15360/1813-9779-2016-4-79-88

Импульсные электрические поля – нетермические методы обработки для сохранения продуктов питания

Authors: Челомбитько, Марина Александровна, Корко, Виктор Станиславович, Заяц, Алина Олеговна

Subject Terms: сушка пищевых продуктов, сушка микроволновым излучением, технологии обезвоживания сырья, микроволновая вакуумная технология, нетермические методы обработки, продукты питания, сохранение продуктов питания, технологии нетепловой обработки, электропорация

File Description: application/pdf

Relation: Trends in LEAN food production and packaging: Proceedings of the10th International Specialized Scientific and Practical Conference, Kyiv, September 15, 2021 = Тренди Lean-виробництва та пакування харчової продукції : матеріали 10-ї Міжнародної спеціалізованої науково-практичної конференції, Київ, 15 вересня 2021 р.; https://rep.bsatu.by/handle/doc/15206; 664

Availability: https://rep.bsatu.by/handle/doc/15206